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THE EFFECT OF VASOACTIVE INTESTINAL PEPTIDE ON CHLORIDE CONDUCTANCE IN 
AIRWAY EPITHELIAL CELLS. 
Shelagh A. Houghton (Sponsored by Marie E. Egan, M.D.). Department of Pediatrics, Yale University, 
School of Medicine, New Haven, CT. 
The aim of this study was to characterize the effect and describe the mechanism of action of 
vasoactive intestinal peptide (VIP) on chloride conductance in tracheal epithelial cells. 
Two established cell lines were examined using single channel inside-out excised patch clamping 
technique: the IB3-1 line, a cell line from a cystic fibrosis (CF)-affected child, and the S9 line, obtained by 
transfection of the IB3-1 line with wild-type cystic fibrosis transmembrane conductance regulator (CFTR). 
All cells were pretreated with VIP (lpM) for ten minutes and then examined in both cell-attached and 
excised patch mode. If channel rundown occurred in the excised mode, ATP (ImM) was added to the 
bathing solution. 
In the IB3-1 line, 69% (9/13) of patches demonstrated no channel activity. The remaining four 
patches (31%) contained channels characterized by a large amplitude and activation only after depolarizing 
voltages > +70mV. Both attributes are consistent with outwardly rectifying chloride channel (ORCC) 
activity. These channels displayed no rundown and were not affected by addition of ATP. 
In the S9 cell line, 83% (10/12) of excised patches demonstrated channel activity consistent with 
CFTR chloride channels. Mean conductance was 10.4pS±0.39pS. Channel activity ran down in 80% 
(8/10) of these channels; 75% (3/4) of patches treated with ATP after rundown demonstrated restoration of 
channel activity. In addition, 50% (5/10) of S9 patches with channels also demonstrated a larger channel 
suggestive of ORCC. 
This study strongly suggests that VIP increases chloride conductance by stimulation of CFTR 
chloride channels in the apical membrane. VIP may activate CFTR directly, or indirectly through the 
second messenger cAMP. The data supports potential therapies that would maximize or complement 
cAMP-stimulated chloride current, particularly in patients with CF mutations productive of suboptimally 
functioning CFTR. 
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1. Introduction 
1-1. Inflammation 
Inflammation is fundamentally a protective response initiated against substances 
or organisms that threaten the body’s homeostatic mechanisms. The inflammatory 
response begins when cellular injury occurs by a variety of insults, including microbes, 
toxins and mechanical stress. It continues even when the offending agent is eliminated, 
as the host attempts to repair necrotic tissue and remove cellular debris. However, in 
both normal and pathophysiology, the inflammatory response can extend beyond the 
scope of constructive repair, and, in fact, cause tissue damage with exacerbation or 
development of symptoms unrelated to the initial condition. 
The basic sequence of events in the acute inflammatory response is similar against 
many forms of injury. Immediately following tissue injury, major changes occur in blood 
vessels supplying the violated area which permit both increased blood flow and 
transmigration of leukocytes from the blood to the interstitium. Vessels become dilated 
and increasingly permeable. This leads to slowing of the circulation as protein-rich fluid 
flows into the interstitium, leaving predominantly red blood cells in vessels. With stasis, 
leukocytes extravasate, first adhering to the endothelium and then squeezing through 
junctions between endothelial cells into the interstitial space. Having escaped the 
confines of the vasculature, leukocytes move toward the site of injury by chemotaxis and, 
having reached the appropriate site, are activated by distinct chemical and mechanical 
signals. The leukocytic response to membrane changes is manifest as release of 
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lysosomal enzymes, oxygen metabolites, and products of arachidonic acid metabolism 
(prostaglandins and leukotrienes). These products are essential mediators of the 
inflammatory response and form part of the amplification cascade following acute injury. 
However, unlike cellular immunity, these defenses are non-specific and can paradoxically 
cause direct endothelial damage and tissue injury. When this response proceeds 
unchecked, the inflammatory response itself engenders a milieu within the affected 
system characterized by edema, poor perfusion, fibrosis, and creation of an environment 
suitable for superimposed bacterial or fungal infection. 
Signaling required for the necessary vasodilation, increased permeability, and 
chemotaxis stems from one of many distinct inflammatory mediators, which may be 
derived from damaged cells, plasma, mast cells, and nerve endings. Cells stimulated by 
mechanical or chemical disruption are the source of arachidonic acid metabolites, the 
prostaglandins and leukotrienes. Activated plasma triggers four interrelated cascades: 
the complement, kinin, fibrinogen, and coagulation systems. Activated mast cells and 
nerve endings of both the autonomic and non-adrenergic, non-cholinergic systems 
produce neuropeptides, such as VIP, Substance P, and the tachykinins. How these 
inflammatory mediators modulate function specifically in the human respiratory tract is 
important in understanding both the etiology and possible therapeutic options in lung 
pathophysiology. 
1-2. Physiologic Role of Inflammation in the Lung 
In the respiratory system proper functioning of the inflammatory response 
prevents chronic infection or colonization by pathogens and eradicates chemical or 
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mechanical irritants. The epithelial layer lining the respiratory tract is an integral part of 
the defense system. Humans rely on the mechanical barrier of the nasal mucosal layer, 
immunologic systems in the conducting airways and alveoli, and the mucociliary ladder 
(Welsh, 1988). 
Airway secretions provide the essential conduit of the mucociliary clearance 
ladder. The ladder serves mechanically to remove inhaled matter from the lung through a 
combination of ciliary movement and fluid wash. Cilia are immersed in a 6 pm-thick 
layer of fluid, the aqueous sol or periciliary layer. Quantity and quality of the fluid layer 
are controlled by electrolyte transport through the respiratory epithelium. The mucus 
layer, which is 5 to 10 pm thick, covers the periciliary layer, and traps foreign particulate 
matter. Mucus is produced primarily by non-ciliated goblet cells and also, in the larger 
conducting airways, by submucosal glands. Beating of the cilia in the periciliary fluid 
establishes coordinated movement by which foreign matter trapped in the mucus layer is 
transported toward the glottis (Welsh, 1988). 
Inflammatory mediators promote changes in mucus production, vascular 
permeability, smooth muscle contractility, and fluid and ion movement that collectively 
enhance both recruitment of opsonic and phagocytic elements into disrupted areas and 
clearance of noxious material from the respiratory tract along the mucociliary ladder. 
The normal response to infection or irritation consists of release of mediators that 
stimulate increased secretions into the airway lumen to wash out irritants and supply 
phagocytic elements. These secretions can be too voluminous, as in asthma, which leads 
to airway plugging, or insufficient, as in cystic fibrosis, with consequent hyperviscosity 
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and sludging. In either case, bacteria and airway irritants persist. In addition, the 
ongoing nidus of irritation prompts continuous inflow of host cellular elements (PMN’s, 
lymphocytes, and macrophages) which, as described above, can cause direct damage. 
The cellular mechanisms by which inflammatory mediators such as leukotrienes, 
prostaglandins, VIP, Substance P, and the tackykinins increase airway secretions remain 
unclear. Understanding the details of these pathways may ultimately provide therapeutic 
options in the treatment of severe respiratory diseases. 
1-3. Regulation of Airway Secretions 
Both chloride secretion and sodium absorption influence the composition and 
quantity of the fluid bathing the respiratory epithelium. The relative contribution of 
either of these functions is determined by the neurohormonal milieu and the anatomical 
region of the airway (McCann and Welsh, 1990). An ability collectively to secrete fluid 
depends on the structure of each epithelial cell lining a particular portion of the airway. 
Cells are polarized, with an apical aspect lining the lumen, and a basolateral face lining 
the interstitial space. Membrane at either end has properties specific to the region of the 
respiratory system and reflects the physiological role of the cell. The isolation of certain 
transporters or channels to the apical or the basolateral pole permits either net absorption 
or net secretion. Epithelial cells lining the respiratory tract are joined along their apical 
(lining the lumen) borders by tight junctions. The resulting wall of cells creates a semi- 
permeable barrier: ions, certain solutes, and water may move across the barrier, while 
other molecules and charged particles may not pass. Two pathways exist by which 
solutes may move: through the tight junctions and between cells, referred to as the 
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paracellular pathway, or through channels or transporters in the apical membrane of the 
cells themselves, also known as the cellular pathway (Welsh, 1988). 
The balance between sodium absorption and chloride secretion from the apical 
membrane of respiratory epithelium is the primary factor in determining the degree of 
fluid production. Differences in the magnitude of chloride secretion and net luminal fluid 
flow in various parts of the human airways depend on the prevalence of chloride channels 
correlating with the functional demands of the cells in the region. The mechanism of 
chloride secretion is otherwise the same (Figure 1). First, chloride enters cells in a 
neutral cotransport with sodium and potassium along the basolateral membrane against 
an electrochemical gradient (more intracellular than extracellular chloride). The nature of 
this cotransporter may differ among cell types, but is likely to be either a Na /Cl 
cotransporter or a Na7 K+/C1‘ cotransporter (McCann and Welsh, 1990). Energy 
necessary for this process is provided by coupling with sodium, which is moving down an 
electrochemical gradient created by the Na+,Kf-ATPase also located in the basolateral 
membrane. The basolateral membrane has potassium channels, which permit passive 
movement of potassium down the chemical gradient created by both the Na+,K7-ATPase 
and the chloride transporter. The potassium channels are important in maintaining 
negative intracellular voltage (Welsh, 1988). 
The second step in chloride secretion through the cellular pathway involves 
specific chloride channels located in the apical membrane. Several distinct chloride 
channels have been identified in the apical membrane of both epithelial and nonepithelial 
mammalian cells. These channels, which include the cystic fibrosis transmembrane 
conductance regulator (CFTR) chloride channel, an outwardly rectifying chloride channel 
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Lumen Interstitium 
Key to Symbols 
ATPase Cotransporter 
Ion Channel 
Figure 1. Mechanism of chloride secretion by airway epithelial cells. The 
basolateral membrane contains a Na7Cl' or a Na7K7CT cotransporter, the Na+,Kf 
ATPase, and a K+ channel. The cotransporter exploits the Na+ gradient generated by the 
ATPase to accumulate chloride within the cell. Opening of a channel in the apical 
membrane permits efflux of chloride down its electrochemical gradient. In a non-leaky 
epithelium, K+ leaves the cell on the basolateral side to compensate for the charge lost by 
the cell in the secretion of chloride. 
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(ORCC), and a calcium-activated chloride channel, are responsible for the movement of 
chloride from the serosal to the mucosal side of the cell. Fruitful functional studies have 
utilized apical membrane, whole-cell, and single channel patch clamp techniques to 
measure conductance and voltage variability. Essential to distinguishing chloride 
channels is examination of the individual functional profile. Average chloride 
conductance, current-voltage (I-V) relationship, voltage dependence, and reaction to 
agonists or antagonists comprise a set of features apparently unique to each variety of 
channel. 
1-3.1. CFTR Chloride Channel 
In the early 1980’s electrophysiologic studies of cystic fibrosis (CF) affected 
sweat ducts (Quinton, 1986) and airways (Knowles et al., 1983) demonstrated that the 
primary defect in CF was a decrease in chloride permeability in epithelial cells. In 1989, 
the genetic mutation associated with CF was identified. The gene that is defective in CF 
encodes for the cystic fibrosis transmembrane conductance regulator (CFTR) (Riordan et 
ah, 1989)(Bear et ah, 1992). Mutations in CFTR eliminate or reduce chloride 
conductance from the apical membrane of predominantly epithelial cells and, clinically, 
result in the phenotype characteristic of cystic fibrosis, the most common lethal genetic 
disease in Caucasians. Unclear, however, was the issue of whether the physiologic defect 
resided with an improperly functioning channel or with defective regulation of a normal 
channel. Conjecture regarding the role of CFTR revolved around two primary options: 
either CFTR was itself a chloride channel or CFTR was a regulator of chloride, and 
perhaps other, ionic channels. 
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Prior to identification of CFTR, excised, inside-out single channel patch studies 
suggested a link between protein kinase A (PKA) and intracellular nucleotides, and 
activation of chloride channels. While addition of the catalytic subunit of PKA and ATP 
opened chloride channels in membranes from normal cells, similar manipulation of CF- 
affected cells failed to increase chloride movement. This data supported early theories 
that the CF defect presented a problem distal to the receptor or initiation of a second 
messenger cascade, perhaps residing in a regulatory protein or the channel itself 
(Schoumacher et al., 1987)(Greger et ah, 1988)(Li et ah, 1988). However, identification 
of CFTR was necessary to complete the puzzle. 
The structure of the protein predicted by the amino acid sequence consists of two 
sets of six transmembrane domains, two nucleotide binding folds, and an intracellular 
hydrophobic regulatory, or R, domain (Figure 2). This structure resembles that of the 
ATP binding cassette, or ABC, family of transporters, a group of proteins that mediate 
selective movement of solutes across membranes (Higgins, 1995). Among ABC 
transporters are the P-glycoproteins, which transport verapamil and vincristine and confer 
drug resistance in bacteria and cancer cells; the SUR receptor for sulphonylureas; and 
the sterile 6 protein of yeast which transports the “a” mating factor (Higgins, 1995). All 
ABC transporters share a common structure, with four fused or independent core 
domains. Two membrane spanning domains straddle the core and serve as the pathway 
through which solute crosses the membrane; these transmembrane domains determine 
the specificity of the channel by their particular amino acid sequence. Alteration of the 
anion selectivity after mutation of four basic amino acids in the CFTR transmembrane 
domain justified belief that CFTR itself is a chloride channel (Anderson et al., 1991b). In 
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Cl 
Figure 2. Cystic fibrosis transmembrane conductance regulator. The structure, as 
predicted by the amino acid sequence, consists of two membrane-spanning domains (TM) 
with six membrane spanning segments each, two nucleotide binding domains (NBD), and 
an intracellular regulatory domain (R). The R domain contains multiple consensus 
phosphorylation sites for priming of the channel by PKA and PKC (denoted by •). 
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addition, two putative nucleotide-binding domains on the cytosolic surface provide 
energy for solute movement via ATP hydrolysis in many ABC transporters (Hyde et al., 
1990)(Ames and Lecar, 1992)(Higgins, 1995). The role of these domains in CFTR is 
discussed below. 
The CFTR chloride channel is singular among ABC transporters in that it is an 
ion channel, not an active transporter. In addition to being a channel itself, CFTR also 
regulates several other ion channels, including the outwardly rectifying chloride channel 
(see discussion below); sodium channels, with increased sodium absorption through 
dysfunctional regulation by CFTR of the amiloride-sensitive sodium channel, ENaC 
(Chinet et al., 1994); and calcium-activated chloride channels, which are up-regulated in 
cystic fibrosis (Grubb et al., 1994). Consequent derangement of these other channels may 
contribute to the pathophysiology of CF. 
Also unique to CFTR among ABC transporters is the regulatory, “R” domain, 
which contains multiple phosphorylation sites for cAMP-dependent protein kinase A 
(PKA) and protein kinase C (PKC) (Riordan et al., 1989)(Rich et al., 1991). The current 
working model for CFTR pictures the protein forming a chloride channel in which the 
transmembrane domains form the pore and the R domain functions as a channel plug, 
somewhat like a ball fitting into the pore. Phosphorylation of the R domain by PKA 
prepares the protein, either by effecting a conformational change or by creating an 
electrostatic repulsion of the R domain away from the membrane, to be accessible to a 
chloride ion (Cheng et al., 1991). When the R domain blockade is removed, binding of 
ATP at the first NBD and subsequent hydrolysis permits channel opening. Binding and 
hydrolysis of ATP at the second NBD allows channel closure. Dephosphorylation of the 
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R domain by specific phosphatases results in actual closure of the channel (Tabcharani et 
ah, 1991)(Berger et ah, 1993)(Hwang et ah, 1993)(Davis et ah, 1996). Evidence to 
support this current model will be discussed in subsequent sections. 
As described, the CFTR channel is regulated by PKA phosphorylation and 
intracellular ATP. Agents that increase cAMP, such as B-adrenergic agonists, forskolin 
(an adenylate cyclase activator), and 3-isobutyl- 1-methylxanthine (IBMX, a 
phosphodiesterase inhibitor), effectively increase apical chloride conductance by 
initiating the second messenger cascade leading to activation of PKA. 
Electrophysiological studies have confirmed the unique functional characteristics of this 
channel. At baseline, the CFTR channel exhibits little or no chloride conductance; 
addition of cAMP results in a dramatic increase in chloride current (Anderson et ah, 
1992). The channel is not affected by intracellular calcium; the response to cAMP 
persists in cells which have been buffered with calcium chelators, such as EGTA. The 
CFTR chloride channel is a linear, 8-10pS chloride channel located in the apical 
membrane (Cliff et ah, 1992) and lacks time-dependent voltage effects (Anderson et ah, 
1991c). The channel is further characterized as being selective for anions over cations, 
and by having an anion selectivity preference of bromide>chloride>iodide>fluoride 
(Anderson and Welsh, 1991). Slight outward rectification seen with high pipette 
chloride concentration is most likely secondary to the pipette-to-cell chloride gradient, 
and is not of physiologic consequence (Cliff et ah, 1992). Physiologically, it is classified 
as non-rectifying (Overholt et ah, 1995). This channel is inhibited by glibenclamide, 
which was previously thought to be a specific K+ channel blocker (Rabe et ah, 1995). 
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1-3.1.1. cAMP Dependence of CFTR 
Studies using recombinant CFTR to transfect both CF-affected cells and normal 
cells that do not ordinarily express CFTR have demonstrated the role of cAMP in channel 
activation. Whole cell patch clamp studies using CF airway epithelia and a CF pancreatic 
cell line (CFPAC-1) demonstrated an increase in chloride conductance after transfection 
with CFTR (Anderson et al., 1991c) (Drumm and Collins, 1993). Additional studies in 
which nonepithelial mammalian cells without endogenous CFTR were transfected with 
recombinant CFTR demonstrated generation of chloride current activated by cAMP 
agonists including forskolin, IBMX, and dccAMP (a membrane-permeable form of 
cAMP). Cell lines employed included NIF1/3T3 fibroblasts (Anderson et al., 1991b), 
Chinese hamster oocytes (CFIO) (Anderson et al., 1991c), and HeLa cells (Anderson et 
al., 1991c). When these same cell lines were transfected with mutant CFTR vector 
(AF508, deletion of phenylalanine at position 508, the most common mutation), no 
increase in chloride conductance was observed upon stimulation. Moreover, when T84 
cells, human colon carcinoma epithelial cells with high endogenous expression of CFTR, 
were transfected with CFTR, cAMP-activated halide permeability was greater than that 
observed with non-transfected cell lines. This indicates that overexpression of CFTR 
causes an increased anion permeability, and supports the suggestion that CFTR effects a 
dose-related response in cAMP-mediated anion conductance (Anderson et al., 1991c). 
Similar single channel studies have produced data with results supporting the whole cell 
studies linking CFTR to a reversible cAMP-mediated increase in chloride current (Bear et 
al., 1991)(Dalemans et al., 1991 )(Kartner et al., 1991)(Anderson et al., 1992). 
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Cells expressing endogenous CFTR display cAMP-activated chloride 
conductance with functional properties similar to those described in cells transfected with 
known CFTR. In order for a chloride current to contribute to the net movement of fluid, 
the current must originate in the apical membrane of the cell. To analyze apical 
membrane chloride movement specifically, normal cell lines were treated with nystatin, 
which functionally eliminates the basolateral membrane, and then grown on permeable 
supports. In this setup, normal airway and intestinal epithelium (T-84, Caco-2, and HT- 
29) displayed an increase in apical membrane chloride conductance upon addition of 
cAMP. In contrast, epithelial cells cultured from CF-affected airways did not 
demonstrate an increase in chloride conductance with addition of cAMP (Anderson and 
Welsh, 1991). Experiments utilizing the Caco-2 cell line transfected with a mutant 
regulatory subunit of cAMP-dependent protein kinase have shown a decreased chloride 
efflux in response to potent cAMP agonists, including forskolin, membrane permeable 
analogs of cAMP, VIP, PGE2, and isoproterenol. These results indicate that cAMP and 
PKA are essential components of secretogue-regulated chloride conductance (Krolczyk et 
al., 1995). The similarities between the functional characteristics of chloride channels 
observed in these studies of the apical membrane of normal and CF-affected cells 
compared with the properties of channels seen in CFTR-transfected cells is strong 
evidence that the cAMP-regulated chloride channel observed in the apical membrane of 
natural epithelium operates through CFTR. 
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1-3.1.2. Role of the Regulatory Domain 
Other studies have further elucidated the mechanism of action of PKA 
phosphorylation and ATP binding and hydrolysis, creating a picture of the integrated 
functioning of the R domain and nucleotide binding domains. One model posits the R 
domain as a structural inhibitor, which physically blocks the channel. This theory is 
supported by studies in which CFTR with a deleted R domain functions exactly as a wild- 
type CFTR chloride channel except that it is constitutively open (Rich et al., 1991). In 
wild-type CFTR, one of four serine residues in the R domain must be phosphorylated for 
channel activation (Cheng et al., 1991). Although data had suggested that simultaneous 
mutation of all four serine residues was required to prevent cAMP-dependent channel 
activation, recent studies demonstrate that mutant CFTR lacking all four serine residues 
can still be phosphorylated to an active chloride channel, but that the open state 
probability is reduced (Rich et al., 1993). The implication that other regulatory sites 
within the R domain exist is supported by experiments locating additional phosphorylated 
serines in the R domain (Seibert et al., 1995). 
CFTR chloride channels require PKA for initiation of channel activity and ATP 
for channel opening. Structural characterization of the R domain suggests that initiation 
of CFTR chloride channel activity by PKA phosphorylation involves conformational 
changes in the R domain wrought by the additional negative charge of the phosphate 
(Rich et al., 1993)(Dulhanty and Riordan, 1994). This change exposes the pathway 
through which ions traverse the membrane. Although CFTR requires PKA to prime the 
channel, PKA is not required for continued channel activity. The CFTR channel can 
remain open, in the absence of specific phosphatases, if PKA is removed. However, the 
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presence of specific phosphatases can result in dephosphorylation of the R domain and 
subsequent rundown of channel activity, which is restorable by addition of the catalytic 
subunit of PKA and ATP (Tabcharani et ah, 1991). 
1-3.1.3. Role of the Nucleotide Binding Domains 
Existence of the two nucleotide binding domains is a feature unique to CFTR 
among ion channels, but characteristic of the ABC family of transporters. When NBD’s 
exist in other proteins, they often serve to hydrolyze ATP as a source of energy for 
substrate transport. Understanding of CFTR as a chloride channel that passively 
transports chloride down an electrochemical gradient implies that ATP is not directly 
used as energy currency to move chloride. However, ATP and ATP derivatives do bind 
to recombinant peptides corresponding to nucleotide binding domains in vitro (Thomas et 
ah, 1991). Moreover, mutations in one or both of these domains, particularly in NBD1, 
accounts for a disproportionate number of mutations responsible for CF, implying that 
whatever reaction occurs there is required for normal function (Cutting et ah, 
1990)(Kerem et ah, 1990). Thus, the question remains whether hydrolysis occurs after 
binding, and, if so, whether it serves a regulatory or direct channel gating function. 
Several lines of evidence bolster the argument that hydrolysis is an essential 
component of CFTR function. Although the channel can remain open in the absence of 
PKA., the channel closes if ATP is removed after PKA phosphorylation, manifest as 
observed rundown of activity after channel excision. Resupply of ATP, as well as other 
hydrolyzable nucleotide triphosphates (ATP>GTP>ITP=UTP>CTP; 8-azido-ATP), to 
the cytosolic surface of CFTR results in reopening of the channel (Anderson et al., 
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1991a)(Travis et al., 1993). Nonhydrolyzable ATP analogs, such as compounds with 
modified polyphosphate moieties (ADP, AMP-PNP), and Mg2+-free ATP are not 
effective in opening the channel. ATPyS , which is an analog of ATP with a slow rate of 
hydrolysis, substitutes for ATP in PKA phosphorylation, but does not successfully open 
the channel (Anderson et al., 1991a)(Nagel et al., 1992). In addition, the open probability 
(P0) of the channel increases directly as a saturable function of ATP concentration 
(Venglarik et al., 1994). 
While ATP is required for continued channel activity, ADP inhibits ATP- 
dependent CFTR channel gating. In the presence of ATP, increasing concentrations of 
ADP progressively inhibit current in a pattern consistent with competitive inhibition. 
Mutation of three sites in the second nucleotide binding domain (NBD2) abolishes this 
inhibitory effect, suggesting that the inhibitory effect resides with NBD2 (Anderson and 
Welsh, 1992). Inability of ADP to open the channel (Anderson et al., 1991a) and 
simultaneous competition with ATP for binding at the NBD, summarily prevents channel 
opening when ADP is present (Schultz et al., 1995). Understanding this relationship 
between the ratio of ATP and ADP leads to an explanation of how the metabolic state of 
the cell might determine certain cell activities. In this scheme, CFTR is able to sense the 
cell’s energy level and modulate chloride secretion accordingly. 
Interestingly, function of the two NBD’s is not equivalent. Mutations in two 
conserved regions thought to represent sites for ATP binding found in both NBD1 and 
NBD2, the Walker A and Walker B consensus sequences, produce strikingly different 
results. Mutation of lysine of Walker A results in a decrease in sensitivity to channel 
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activation, while the opposite is true of mutation of the same lysine in Walker A of NBD2 
(Smit et al., 1993). This recent work supports previous studies of NBD mutations 
proposing two ATP binding sites with differential functions (Anderson and Welsh, 1992). 
Inorganic phosphate analogs, including V04 and BeF3, inhibit enzymes that catalyze 
phosphoryl transfer reactions (e.g. ATPases). When added to cell patches in which 
channels have been opened by addition of ATP, the channels become stabilized, or 
“locked,” in the open conformation (Baukrowitz et al., 1994). Furthermore, AMP-PNP, 
which is a nonhydrolyzable analog that binds only at NBD2, could not open the channel, 
but did prolong P0 of channels already activated by ATP (Hwang et al., 1994). This data 
supports models in which hydrolysis at one or both NBD’s contributes an essential 
component to channel gating. In these schemes, the two NBDs appear to function 
differently, with binding and hydrolysis of ATP at NBD1 effecting channel opening, and 
similar action at NBD2 resulting in channel closure (Davis et al., 1996). 
Despite this growing collection of data which seems to support the role of ATP 
hydrolysis, controversy persists. While the NBD’s can have a regulatory function via 
nucleotide binding without hydrolysis (i.e. via ADP competitive inhibition), the question 
remains whether a regulatory role exists that requires nucleotide hydrolysis. Studies of 
epithelia in which the basolateral membrane was permeabilized with a-toxin produced 
data supporting the ability of non-hydrolyzable ATP analogues to augment apical 
chloride conductance. In these experiments involving human sweat ducts (Bell and 
Quinton, 1993) and T84 cells (Quinton and Reddy, 1992), nonhydrolyzable ATP 
analogues activated previously phosphorylated CFTR channels. This appears to 
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contradict the single-channel studies described previously. Explanations abound for this 
seeming incongruity. Research indicates that certain ATP analogues react with some, but 
not all, ATPases (Moos et al., 1960). Thus, in order to discuss whether hydrolysis occurs 
at an NBD, one must first prove that the ATP analogue in question is in fact interacting 
with the protein. For example, AMP and non-hydrolyzable analogues (AMP-PCP, AMP- 
PNP, AMP-PCP, ATPyS) have polyphosphate moieties significantly different from ATP, 
and may simply not interact with the hydrolytic enzyme portion of CFTR, or may require 
other conditions, such as a highly phosphorylated state, to bind adequately (Schultz et ah, 
1995). A second line of reasoning relies on differences in experimental conditions to 
explain inconsistent outcomes. For example, experiments conducted at 25°C in the 
continued presence of PKA produced a P0 greater than that seen in experiments in which 
AMP-PNP was added. This indicates that the nonphysiologic temperature induces a 
different kinetic state, independent of the addition of the nonhydrolyzable ATP analogue 
(Schultz et ah, 1995). 
1-3.1.4. Role of Other Kinases 
The role of protein kinase C (PKC) in activation of the CFTR chloride channel is 
less clearly defined. Recent work has identified both calcium-dependent and calcium- 
independent isoforms of PKC-activated CFTR chloride channels. In the calcium- 
independent model, PKC directly phosphorylates CFTR (Berger et ah, 1993). However, 
conflicting studies report that while activation of PKC causes a modest increase in the 
magnitude of CFTR chloride currents, it more significantly confers a marked reduction in 
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stability of CFTR chloride currents in pancreatic duct cells (Winpenny et al., 1995). 
Even when PKC functions in CFTR activation, it alone stimulates only approximately 
10% of the current stimulated by PKA (Tabcharani et al., 1991)(Berger et al., 1993). 
1-3.2. Outwardly Rectifying Chloride Channel 
Prior to identification of CFTR, the chloride channel responsible for the CF defect 
was thought to be an outwardly rectifying, 30-50 pS channel, called the outwardly 
rectifying chloride channel (ORCC). Like other chloride channels, the ORCC has 
distinct functional and electrophysiologic properties that distinguish this channel. The 
channel has an ion selectivity sequence of iodide>bromide>chloride, demonstrates 
voltage dependence, and is sensitive to inhibition by 4,4’ diisothiocyanostilbene-2,2’ 
disulfonic acid (DIDS). Thus, the biophysical properties differ completely from those 
now known to describe the small conductance CFTR chloride channel (Table 1). 
However, early research on the molecular basis for the CF defect described 
aspects of ORCC functioning that appeared to coincide with expectations for the CF gene 
product. Data indicated that the ORCC was activated by cAMP agonists in cells without 
the CF defect (Frizzell et al., 1986; Berger and Welsh, 1991) and, inconsistently, by the 
catalytic subunit of PKA and PKC (Li et al., 1988)(de Jonge et al., 1989)(Hwang et al., 
1989)(Jetten et al., 1989). In contrast, activation of ORCC by cAMP and PKA was 
defective in tissue from patients with CF (Chen et al., 1989)(Hwang et al., 1989)(Jetten et 
al., 1989). Of note, even in CF-affected cells, the channel could be activated with trypsin, 
strong depolarization, and excision at 37°C (Schoumacher et al., 1987)(Hwang et al., 
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Table 1 
Properties of Apical Chloride Channels 
Biophysical Properties CFTR ORCC 
Conductance 8-10 pS 20-30 pS 
I/V Curve Linear Outward rectifying 
Inhibitors DPC 
Glibenclamide 
DIDS 
Activation PKA 
ATP 
(intracellular) 
Voltage 
ATP ! 
(extracellular) 
Ion Selectivity Br > Cl > T T > Br > Cl 
Definition of abbreviations: CFTR =cystic fibrosis transmembrane conductance regulator; 
ORCC=outwardly rectifying chloride channels; I/V curve=current voltage relationship; 
DPC=diphenylamine-2-carboxylic acid; DIDS=4,4’ diisothiocyanostilbene-2,2’ disulfonic acid; 
ATP=adenosine triphosphate 
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1989). Appearance of channel activity only under these conditions implied that ORCC 
was present in CF patients, but improperly regulated, and that dysfunctional regulation of 
this channel represented the primary defect in CF. Subsequent identification and 
expression of CFTR lead to research that illustrated singular properties of CFTR which 
were different from those expected for ORCC. Expression of CFTR cDNA in various 
systems did not produce a channel with biophysical characteristics consistent with those 
observed for ORCC (Bear et al., 1992). Furthermore, the presence of currents resembling 
ORCC in ‘knockout’ mice (genotype CFTR(-/-)) disclosed additional evidence that the 
two channels were distinct, and that lack of ORCC was not the primary defect in CF 
(Gabriel et al., 1993). 
Ensuing work has substantiated that ORCC is a distinct chloride channel and a 
unique protein, but is regulated by CFTR. The CFTR protein is required for PKA 
activation of ORCC (Egan et al., 1992)(Gabriel et al., 1993)(Jovov et al., 1995). 
Expression of recombinant CFTR in CF-affected cell lines results not only in restoration 
of chloride channel activity, but also reestablishes PKA activation of ORCC (Egan et al., 
1992) (Gabriel et al., 1993) (Schwiebert et al, 1994). Exactly how CFTR regulation of 
ORCC transpires remains unclear. One model postulates that PKA-phosphorylated 
CFTR conducts ATP out of the cell. On the extracellular surface, ATP acts as an 
autocrine stimulator of ORCC through P2u purinergic receptors, which then act through 
direct coupling to ORCC or by activation of a G-protein associated cascade (Schwiebert 
et al., 1995a). Interestingly, ATP had no effect on ORCC activity without CFTR 
membrane incorporation, or without PKA and ATP presence on the cytosolic side of the 
channel (Ismailov et al., 1996). Supporting the role of extracellular ATP in activation of 
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ORCC is the adverse effect that ATP scavengers such as hexokinase display on ORCC 
chloride current. In these experiments, hexokinase converted ORCC from a PKA- 
sensitive mode to a PKA-insensitive mode, in the continued presence of wild-type CFTR 
(Jovov et al., 1995)(Schwiebert et al., 1995a). 
Despite these efforts to understand how CFTR may regulate other channels, it is 
increasingly clear that cross regulation between channels and cellular proteins is 
exceedingly complex. Current investigations link both cAMP-regulated chloride 
channels, ORCC and CFTR, as a complex jointly regulated by a G protein, Gai_2. Data 
implies that Gai_2 specifically inhibits ORCC, perhaps in concert with CFTR, creating a 
system of negative feedback inhibition of cAMP-activated chloride current. In this study 
of a normal human airway epithelial cell line (9HTEo ) expressing both CFTR and 
ORCC, stimulation of the G protein with GTP and GTPyS decreased the open probability 
(P0) of ORCC, while inhibition of the G protein by GDPBS increased P0. Addition of 
pertussis toxin, which uncouples portions of the heterotrimeric G protein from the 
receptor, also increased P0 and restored cAMP-activated chloride current in airway cells 
from CF patients (Schwiebert et al., 1995b)(Ismailov et al., 1996). Of note, uncoupling 
of the G protein from ORCC altered the rectification characteristics of ORCC and 
restored PKA sensitivity in the absence of CFTR, suggesting that both rectification and 
PICA sensitivity is influenced by the G protein (Ismailov et al., 1996). Additional results 
support the theory that while CFTR chloride channel conductance may be altered by 
mediating vesicle trafficking and delivery of chloride channels to the membrane, ORCC 
function may receive direct modulation (Schwiebert et al., 1995a). 
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1-3.3. Calcium Activated Chloride Channels 
The calcium-activated chloride channel demonstrates that epithelial chloride 
secretion is regulated by mechanisms involving second messengers other than cAMP. An 
increase in intracellular calcium concentration stimulated transepithelial chloride 
movement in airway epithelia as well as an increase in opening of basolateral potassium 
channels (Willumsen and Boucher, 1989). Initial speculation existed as to whether the 
calcium-activated pathway stimulated a distinct channel, or whether the different second 
messengers each activated the same apical chloride channel. The possibility that the 
pathways culminated in a single final channel was supported by the finding that, like 
cAMP-stimulated ion flow, calcium-stimulated chloride conductance is also defective in 
cystic fibrosis affected intestine (Anderson and Welsh, 1991). However, subsequent 
studies indicated that in both CF affected and normal airway epithelia, addition of 
calcium ionophore A23187 or prostaglandin F2a effected an increase in intracellular 
calcium which brought about an increase in chloride ion movement, without changing 
intracellular cAMP concentration (Hwang et al., 1989)(Anderson and Welsh, 1991). 
Likewise, cAMP- but not Ca2+'regulated chloride conductance is defective in the CF- 
affected mouse oviduct (Leung et ah, 1995). In contrast, colonic cells lines (T84, Caco-2, 
HT-29cl9a) have shown the absence of apical calcium-activated chloride current. The 
presence of chloride conductance in response to an increase in intracellular calcium in 
intestinal cells is most likely due to calcium activation of basolateral potassium channels. 
The resulting hyperpolarization increases the driving force for chloride movement across 
the apical membrane (Anderson et ah, 1992). 
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Multiple lines of evidence support the conclusion that the Ca2-dependent and 
cAMP-dependent pathways operate finally on distinct chloride channels. The 
observation that intestinal cells appear to have a second messenger-activated apical 
chloride channel responsive to cAMP but not to calcium suggested that the two pathways 
were distinct. Stronger distinction is drawn by examining the biophysical characteristics 
between the two channels. Ca2+-activated channels are characterized in T84 colonic tumor 
cells by having a linear I-V relation and time-dependent relaxations of chloride current at 
both depolarizing and hyperpolarizing voltages (Cliff and Frizzell, 1990). Anion 
permselectivity has the sequence iodide>bromide>chloride (Cliff and Frizzell, 1990). 
Addition of D1DS to the basolateral aspect of cultured cells blocks Ca2 '-activated chloride 
current, but has no effect on CFTR chloride channels (Anderson and Welsh, 1991). 
Notably, an increase in both cAMP and Ca2+ results in an additive increase in chloride 
secretion from the apical membrane (Anderson and Welsh, 1991). The combination of 
this data indicates that the Ca2+-dependent pathway may modulate chloride secretion 
through a different channel than the cAMP-dependent pathway. 
1-4. Inflammatory Mediators 
1-4.1. Products of Araehidonic Acid 
Arachidonic acid is released from cell membranes in response to inflammatory 
stimuli and is metabolized to a variety of substances involved in the inflammatory 
process, including the products of cyclooxygenase metabolism (prostaglandins, 
thromboxanes, and prostacyclin) and the products of lipooxygenase metabolism 
(leukotrienes), collectively referred to as eicosanoids. These substances are intricately 
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involved in the pathogenesis and promulgation of a broad spectrum of inflammatory 
disorders, extending from diseases of the respiratory tract, such as asthma and cystic 
fibrosis, to rheumatic diseases, such as arthritis and psoriasis, to resolution of myocardial 
infarction (Holtzman, 1991 )(Sigal, 1991). 
Arachidonic acid is a 20-carbon fatty acid that is a component of the phospholipid 
moiety of cell membranes. When a cell is stimulated phospholipases release arachidonic 
acid, which enters one of several metabolic cascades. The mechanism by which 
phospholipases are activated to release arachidonic acid is thought to involve G proteins 
linked to a calcium dependent second messenger system (Sigal, 1991). After release 
from the cell membrane, arachidonic acid is oxidized by either cyclooxygenase or 
lipoxygenase. Each of these enzymes catalyzes stereospecific insertion of one or two 
molecules of oxygen into arachidonic acid. 
1-4.1.1. The Cyclooxygenase Pathway 
If the cyclooxygenase pathway predominates, products include prostaglandin 
(PG) D2, PGE2, PGF2a, thromboxane A.2, and prostacyclin. The enzyme catalyzes the 
attachment of molecular oxygen at the eleventh carbon of arachidonic acid, with 
subsequent rearrangement to a cyclic endoperoxide with bridging of carbons 9 and 11. 
Introduction by cyclooxygenase of a second molecule of oxygen yields PGG2, while a 
hydroperoxidase function of cyclooxygenase performed on PGG2 produces PGH2. 
Nonsteroidal anti-inflammatory drugs, in particular aspirin via acetylation, inhibit the 
cyclooxgenase activity but not the hydroperoxidase activity of the enzyme. Additional 
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product-specific enzymes convert PGH2 to PGD2, PGE2, and PGF2a (Sigal, 1991). The 
subscript in each prostaglandin denotes the two double bonds in the final structure. In 
platelets, the predominant product of arachidonic acid metabolism is thromboxane A2 
which is formed from PGH2. Prostacyclin is also formed from PGH2, but is produced by 
vascular epithelial cells. 
The biologic actions of the products of cyclooxygenase activity are diverse. 
Thromboxane A2, produced in platelets, has strong vasoconstricting, 
bronchoconstricting, and platelet aggregating effects. In contrast, prostacyclin, produced 
by vascular endothelial cells and both vascular and non-vascular smooth muscle cells, is a 
potent inhibitor of platelet aggregation and a vasodilator. Prostaglandin D2 is the 
principal prostaglandin formed by mast cells upon antigen stimulation through binding to 
IgE receptors (Roberts et al., 1979)(Lewis et al., 1982); it acts like histamine, causing 
strong bronchoconstriction (Sigal, 1991). In addition, PGD isomerase is found in high 
concentrations in the central nervous system, suggesting that PGD2 may have 
neuromodulatory effects. Prostaglandin D2 also inhibits platelet aggregation, inreases 
platelet cAMP concentration, and causes peripheral vasodilation, pulmonary 
vasoconstriction, bronchoconstriction, and airway hyperreactivity (Holtzman, 1991). 
Like PGD2, PGF2a has vasoconstricting and bronchoconstricting effects, but is produced 
by airway epithelial cells. In contrast, PGE2 has distinct vasodilatory and 
bronchodilatory actions in human tracheal epithelium. This occurs by a direct effect on 
smooth muscle and by an inhibitory effect on acetylcholine release. Both PGE2 and 
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PGF2a are present in response to inflammatory stimuli and increase chloride secretion in 
human airway epithelial cells (Eling et al., 1986) (Widdicombe et al., 1989). 
Prostaglandin E2 has been shown to inhibit gastric acid secretion and is cytoprotective, 
enabling the healing of ulcers and preventing further formation. 
1-4.1.2. The Lipoxygenase Pathway 
Lipoxygenases are a group of iron-containing dioxygenases that catalyze insertion 
of one molecule of oxygen into fatty acids with a l,4-cis,cis-pentadiene structure after 
initial stereospecific removal of a hydrogen atom (Holtzman, 1991). Lipoxygenases are 
characterized as 5-, 12-, or 15-lipoxygenase to describe the point of oxygen insertion. 
The first product of each enzyme is therefore 5S-, 12S-, or 15S- 
hydroperoxyeicosatetraenoic acid (HPETE), each of which can be further metabolized to 
leukotrienes, aldehydes, epoxyhydroxy acids, and glutathione adducts (Holtzman, 1991). 
Unlike other enzymes in this pathway, 5-lipoxygenase is specifically stimulated 
by calcium and has a strict substrate specificity, requiring double bonds at carbons 5, 8, 
11, and 14 for optimal leukotriene formation (Holtzman, 1991). The enzyme 5- 
lipoxygenase converts arachidonic acid to 5-HPETE and, subsequently, 5-HPETE to 
leukotriene A4 (LTA4). Leukotriene A4 can either be hydrolyzed to LTB4 or converted 
to LTC4 by addition of glutathione. Additionally, catalytic removal of glutamic acid by 
transpeptidase produces LTD4; removal of a glycine from LTD4 results in LTE4. The 
rate-limiting steps in leukotriene biosynthesis reside in LTA hydrolase and LTC synthase 
(Holtzman, 1991). 
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The 12-lipoxygenase enzyme was the first in this pathway to be described in 
humans, initially in platelets and later in leukocytes (Holtzman, 1991). The first product 
of this branch of the pathway, 12-HPETE, is rapidly reduced to the alcohol, 12-HETE, in 
most cells, and is the primary biologically active product. Both 12-HPETE and 12-HETE 
act as specific inflammatory mediators, notably inducing secretion of neutrophil granules 
and augmenting IgE-mediated mast cell release (Holtzman, 1991). 
Metabolism of 15-HPETE resembles that of 12-HPETE, resulting in production of 
15-HETE. Oxygenation and reduction of 15-HPETE or 15-HETE by 5-lipoxygenase 
yields dihydroxy- or trihydroxy-acids called lipoxin A or lipoxin B (Holtzman, 1991). 
The 15-lipoxygenase pathway appears to predominate in human lung tissue in asthmatics 
(Samuelsson et al., 1987). 
1-4.2. Neuropeptides 
Neuropeptides, including vasoactive intestinal peptide (VIP), Substance P, and the 
tachykinins (neurokinin A and neurokinin B), are a diverse group of peptides released 
from nerve endings of the autonomic and non-autonomic nervous systems. In addition to 
the cholinergic nerves of the parasympathetic system and the adrenergic nerves of the 
sympathetic system, nonadrenergic noncholinergic (NANC) nerves are prominent in the 
gut and the respiratory system, and exert a broad spectrum of physiological effects 
expressed through release of neuropeptides. The influence of neuropeptides on bronchial 
and vascular smooth muscle, ion movement, and leukocyte proliferation and 
degranulation render them intrinsic mediators of the inflammatory response. 
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Physiological response to neuropeptides depends upon localization of receptors and upon 
second messengers in target cells. 
First described in the gut, NANC networks are not responsive to adrenergic or 
cholinergic agonists or antagonists (Richardson, 1979)(Bames, 1984)(Bames, 1986). 
NANC nerves often have opposing actions, with mechanisms exhibiting both 
vasoconstriction and vasodilation, bronchoconstriction and bronchodilation; this 
suggests that several different neurotransmitters are involved at each the synapse. 
Inhibitory NANC (i-NANC) nerves relax airway smooth muscle. In humans, the NANC 
system is the only direct bronchodilating effect because there is no sympathetic 
innervation of human airways (Barnes et ah, 1991). Neurotransmitters involved in this 
bronchodilating property appear to include VIP and nitric oxide in some experimental 
models, although in humans the predominant i-NANC transmitter appears to be nitric 
oxide (Barnes et ah, 1991). Excitatory NANC (e-NANC) elements cause 
bronchoconstriction that is not blocked by atropine (Lundberg et ah, 1987). This non- 
parasympathetic bronchoconstriction is thought to be mediated by tachykinins released 
retrogradely from sensory nerves (Barnes et ah, 1991). 
Contrary to the original conception, the NANC system is not an anatomically 
distinct nervous system but, rather, appears to “fine-tune” the effects of the autonomic 
nervous system. Neurotransmitter components of the NANC system are released from 
autonomic nerves. For example, i-NANC bronchodilation in the human airway may be 
mediated by release of VIP and NO from cholinergic nerves. Vasoconstrictor effects 
result from release of neuropeptide Y from adrenergic nerves. Excitatory NANC 
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bronchoconstriction results from release of tachykinins from sensory nerve endings 
(Barnes et al., 1991). 
1-4.2.1. Vasoactive Intestinal Peptide 
VIP is a 28 amino acid peptide, and is one of the most abundant neuropeptides in 
the human lung (Ghatei et al., 1982). VIP has been localized by immunoreactive analysis 
(VIP-IR) to airways and pulmonary vessels; it has been found in nerves and ganglia in 
the posterior trachea and intrapulmonary bronchi, becoming less prominent as the airways 
become smaller (Lundberg et al., 1984)(Uddman and Sundler, 1987). Few VIP-ergic 
fibers are found peripherally in the smaller bronchioles. As discussed above, VIP is 
usually colocalized in parasympathetic ganglia; however, isolated ganglion cells have 
also been demonstrated, which usually perform like cholinergic nerves (Barnes et al., 
1991). The pattern of distribution largely parallels that of parasympathetic nerves, which 
is consistent with the colocalization of VIP and acetylcholine (Laitinen et al., 1985). 
Consistent with observation of correlated function, VIP-ergic neurons are found within 
bronchial and vascular wall smooth muscle and surrounding submucosal and serous 
glands (Barnes et al., 1991). Although receptors for VIP have been discovered in airway 
epithelium, no VIP-ergic fibers have been (Said, 1991). 
Like B-adrenergic agonists, VIP effects proceed through activation of a G protein 
and subsequent second messenger cascade mediated specifically by adenylyl cyclase. 
Cellular response to binding of VIP at membrane receptors involves activation of 
adenylyl cyclase and subsequent increase in intracellular cyclic AMP (cAMP). This 
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knowledge has enabled identification of specific high affinity receptors by 
immunocytochemical detection of increases in cAMP (Lazarus et al., 1986). Localization 
of VIP receptors has also been mapped using autoradiography (Carstairs and Barnes, 
1986). Results of these investigations demonstrate a high density of VIP binding in 
pulmonary vascular smooth muscle, in smooth muscle of large airways, surrounding 
submucosal serous and mucous glands (of the ferret), and in the ciliated and basal cells of 
canine tracheal epithelium (Lazarus et al., 1986)(Leys et al., 1986). 
VIP has also been found in leukocytes, including neutrophils, eosinophils, 
mononuclear cells, and pulmonary mast cells (O'Dorisio et al., 1980)(Lygren et al., 
1984)(Aliakbari et al., 1987). In addition, VIP receptors are present on the surface of 
cells that constitute the inflammatory response, including murine and human T- 
lymphocytes (Ottaway and Greenberg, 1984), MOLT 4b lymphoblasts (Beed et al., 
1983), human blood monocytes (Guerrero et al., 1981), and rat alveolar macrophages. 
The role of VIP in relation to inflammatory cells has not been completely elucidated, but 
VIP has been shown to inhibit release of histamine from pulmonary mast cells (Undem et 
al., 1983) and may have other characteristic inhibitory or stimulatory features that 
modulate the inflammatory response in the respiratory tract. 
As stated, VIP in vitro is the primary source of relaxation of airway smooth 
muscle; adrenergic antagonists do not inhibit this function. The rich innervation of the 
respiratory tract with VIP-ergic fibers and the consequent bronchodilating effect observed 
with stimulation suggests that VIP may be an essential counterforce to the 
bronchoconstricting effect of parasympathetic stimulation (Barnes et al., 1991). 
Bronchodilation is more prominent in large airways than in smaller bronchioles, which is 
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consistent with the predominant VIP innervation noted in bronchi compared with the 
paucity of VIP-ergic fibers found in bronchioles (Carstairs and Barnes, 1986). Therefore, 
functional bronchodilation by VIP may lie more significantly in large airways than in 
progressively peripheral airways. 
VIP has similar properties in systemic and pulmonary vascular smooth muscle. In 
vitro, VIP has potent relaxant effects on pulmonary vessels, independent of endothelial 
cells, which suggests that VIP acts directly on vascular smooth muscle rather than 
through an intermediate relaxant factor such as nitric oxide (Greenberg et al., 1987). The 
substantially greater number of VIP receptors on pulmonary vascular smooth muscle in 
comparison to bronchial smooth muscle indicates why VIP is approximately ten-fold 
more potent as a vasodilator than as a bronchodilator (Barnes et ah, 1991). The 
consequence of this receptor distribution may be to improve delivery of blood to 
constricted airways during bronchoconstrictive episodes such as asthma (Barnes et ah, 
1991). 
The juxtaposition of VIP-IR nerves with submucosal serous and mucous glands 
results in potent mucus secretion. 35S-labeled glycoprotein secretion of mucus in ferret 
airway in vitro is significantly greater than mucus secretion stimulated by isoproterenol 
(Peatfield et ah, 1983). The mechanism of signal transduction again relies on G-protein 
linked increase in cAMP. 
In dog tracheal epithelium, VIP has been shown to be a potent stimulator of 
chloride ion transport and therefore water secretion (Nathanson et ah, 1983). The effect 
of increased chloride transport across the apical membrane of luminal epithelial cells is 
an increase in luminal fluid, with implications for effectiveness of mucociliary clearance. 
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The presence of significant numbers of VIP receptors in human airway epithelial cells 
suggests that VIP may be an important modulator of this clearance system. 
1-5. Inflammation in Airway Disease 
Evidence suggests that inflammation plays a dominant role in the propagation of 
airway disease, particularly in asthma and cystic fibrosis. In each case, although the path 
of tissue destruction differs, the inflammatory mediators described above are involved. 
Increases in production of mediators result in a concomitant increase in their modulating 
effects on bronchoconstriction, immune function, microvascular permeability, mucus 
secretion, and airway fluid production. Although the effects of the leukotrienes, 
prostaglandins, neurokinins, and neuropeptides on bronchial and vascular smooth muscle, 
submucosal glands, and epithelial cells have been documented, the precise mechanisms 
of action of each of these mediators remain unclear. 
1-5.1. Asthma 
The clinical picture of asthma derives from the pathogical triad of exaggerated 
bronchoconstriction, smooth muscle hypertrophy, and inflammation of the small airways. 
A variety of exogenous factors have been identified as triggers of acute asthma attacks: 
allergens, exercise, cold air, upper respiratory tract infections, environmental pollutants, 
and, in some patients, aspirin. A portion of patients will be identified as having allergic 
asthma. These cases are associated with a personal or family history of allergic diseases, 
and often have increased levels of IgE in the serum. A large proportion of patients, 
however, will present with no family or personal allergy history and will have negative 
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skin and serum tests. They are identified as having idiosyncratic asthma (McFadden, Jr. 
1994). In either case, a tendency toward hyperreactivity in the tracheobronchial tree is a 
commonality, manifest as unstable lung function due, most likely, to inflammatory 
mediators. The degree of inflammation apparent in bronchoalveolar washings parallels 
the clinical severity of asthma (Barnes, 1991). Pathophysiologic evidence of asthma is a 
reduction in the diameter of the airway lumen, brought about by a combination of 
bronchoconstriction, vascular congestion, and thick, tenacious mucus secretions 
(McFadden, Jr. 1994). These manifestations are the result of accumulation of mast cells, 
an increase in the number of circulating CD4 T lymphocytes, and an infiltration of 
eosinophils with an increased propensity to degranulate (Barnes, 1991). 
Inflammatory mediators are prominent components of asthma. Although the role 
of cyclooxygenase products is unclear, the leukotrienes are likely contributors. 
Leukotrienes are potent bronchoconstrictors and increase microvascular leakage. LTD4 
receptor antagonists, MK571 and K1204 219, have significant inhibitory effects on 
exercise or allergen mediated bronchoconstriction (Lewis et al., 1990). 
The NANC system in the lungs, of which VIP is a primary neurotransmitter, is the 
principal determinant of airway and pulmonary vessel relaxation, and a fundamental 
contributor to the secretion of bronchial fluid and mucus. Mast cell trypsin degrades VIP, 
and, if released from mast cells in asthmatic patients, could contribute to neurotransmitter 
depletion (Barnes, 1991), thus tilting the balance between NANC relaxation and 
cholinergic constriction. Data from immunoreactive staining of lung tissue obtained from 
patients with and without asthma demonstrated loss of VIP from pulmonary nerve fibers 
in those patients with fatal asthma, regardless of the severity of inflammation 
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(Ollerenshaw et al., 1989). This study did not answer the question of whether this loss 
was a cause or a result of asthma. Nor could the study conclude whether absent VIP was 
secondary to loss of nerves containing VIP, decreased production of VIP by nerves, or 
increased breakdown of VIP by resident airway enzymes. This data supported a 
hypothesis proposed a decade previously that depletion of VIP in asthmatic patients 
might be the cause of characteristic bronchial hyperresponsivity and inflammation 
(Richardson, 1979)(Matsuzaki et ah, 1980). 
Work with lung tissue from asthmatic patients also demonstrated an increase in 
the density of Substance P-immunoreactive nerves in asthmatic lungs, indicating that 
hypersensitivity could be due to a relative imbalance between the relaxant properties of 
VIP and the constrictor properties of Substance P (Ollerenshaw et ah, 1989). Stimulation 
of sensory nerves on airway mucosa can increase vascular permeability, leading to 
extravasation of plasma proteins into the airway lumen, vasodilation, neutrophil 
adherence, mucus secretion, and bronchoconstriction. Vessels in the pulmonary system 
are exquisitely sensitive to such neurogenic stimulus. Moreover, this effect may be 
potentiated by infection (McDonald, 1992). 
The reduced cross sectional area of the airway lumen in asthma is not due solely 
to bronchoconstriction. Rather, the bronchoconstrictor response is potentiated by the 
degree of amplification of luminal fluid, and its composition, during the inflammatory 
response of asthma. Neurogenic inflammation (via leukotrienes, Substance P, and 
neurokinin A) is associated with leakage from venules lying beneath the epithelium; the 
resultant exudative fluid is rich in protein and inflammatory mediators, which act on the 
airway epithelium to permit leakage into the airway lumen (Yager et ah, 1991). Once 
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across the epithelial barrier, fluid fills the interstices between epithelial folds. The fluid 
filling these spaces directly reduces luminal cross sectional area. In addition, if surfactant 
is not present in these larger airways, the increase in radius of curvature between points of 
epithelium may promote airway closure secondary to high surface tension (Yager et al., 
1991). The net sum is the severe increase in airway resistance observed in asthma. 
A possible therapeutic role for VIP in asthma was investigated in human 
asthmatics even prior to its known role as an anti-inflammatory agent. In normal 
patients, intravenous infusion of VIP had no effect on airway conductance (Palmer et al., 
1986). In contrast, VIP administration resulted in significant bronchodilation, measured 
by improved FEV,, and attenuated histamine-induced bronchoconstriction, in seven 
atopic asthmatics (Morice et al., 1983). Results with inhaled aerosolized VIP have 
varied: in six atopic patients, inhaled VIP reduced airway reactivity to histamine, but did 
not reduce airway resistance independently (Barnes, 1984). In another experiment 
involving patients with severe asthma, inhaled VIP did impart improvement in airway 
conductance, but not to the same degree as inhaled B-adrenergic agonists (Said, 1988). It 
is possible that the lack of bronchodilatory response seen with inhaled VIP may be 
secondary to poor transit of the peptide across the bronchial epithelium (Barrowcliffe et 
al., 1986). 
Absence of VIP in the lungs of asthmatic patients could be a primary solitary 
defect creating a permissive environment with decreased attenuation of 
bronchoconstriction and increased microvascular permeability, two of the hallmarks of 
asthma. In addition, lack of the stimulus of VIP for ion and water transport could deplete 
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luminal secretions, thereby rendering airway fluid thick and immobile. The ultimate 
consequence of decreased VIP, whether absolute or relative to other mediators, might be 
a precarious imbalance in the forces acting on an asthmatic’s lungs. 
1-5.2. Cystic fibrosis 
Cystic fibrosis, an autosomal recessive disorder, is the most common lethal 
genetic disease of Caucasians. The CF gene has been localized to the long arm of 
chromosome 7; the multitude of mutations at this region are responsible for the variety of 
phenotypes characteristic of this disease. The most common mutation, deletion of a 
phenylalanine at position 508 (AF508) which accounts for genotypic makeup of 70% of 
CF patients, results in debilitating disease of the exocrine pancreas function and lung if 
not aggressively treated. With the development of pancreatic enzyme replacement 
therapy, lung disease has become the primary source of morbidity and mortality, 
accounting for 90% of deaths in CF patients (Davis et al., 1996). The clinical features of 
CF are dominated by obstruction of the airways by a thick, tenacious mucus, with 
superimposed bacterial infection and colonization by Pseudomonas aeruginosa. Only 
about 0.1% of CF patients with lung disease have normal sweat chloride concentration 
(Davis et al., 1980). Approximately 85% of patients demonstrate pancreatic insufficiency 
as a result of inspissation of pancreatic ducts, with subsequent fibrosis and deterioration 
in exocrine function (Collins, 1992)(Sferra and Collins, 1993). Associated findings 
include infertility in males due to congenital bilateral absence of the vas deferens, 
meconium ileus, and liver disease. CF is a clinical diagnosis, consisting of sweat chloride 
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concentration greater than 60 mEq/ml, chronic pulmonary disease or pancreatic 
insufficiency, and/or history of CF in a sibling or first cousin (Quinton, 1986). 
In people without CF, the CFTR protein is localized to the apical membranes of epithelial 
cells (Denning et al., 1992b). While AF508 is the most common mutation, there are at 
least 500 other mutations identified (Tsui, 1992), each producing phenotypes of varying 
severity. Variability in the site of mutation parallels the wide array of phenotypic 
manifestations that comprise the clinical spectrum of CF disease. Each of these groups of 
mutations provides a different avenue for therapeutic approaches to the disease based on 
modulation of the specific defect. The mechanism by which the genotypic mutation 
creates an inadequate protein product falls into one of four distinct categories: 
Category 1 Defective Protein Production: This class of mutations includes those 
in which splice site abnormalities, frameshift mutations, or missense mutations produce 
premature stop signals (Tsui, 1992). These proteins are often unstable and, even if 
produced, are either degraded by the cell or have no function. Thus, these mutations 
result in little or no functional CFTR protein anywhere in the cell. 
Category 2 Defective Protein Processing: In this group of CF mutations, CFTR is 
made by the cell, but is inappropriately trafficked. The AF508 mutation falls into this 
class. In sweat duct glands, antibodies directed at CFTR do not localize to the apical 
membrane of cells affected by this mutation (Kartner et al., 1992). Although the reason 
for this mislocalization is not established, errors in the secondary structure producing 
improperly folded protein seem likely. The abnormal structure marks the protein for 
degradation rather than movement to the plasma membrane. Of note, when CFTRAF508 
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is grown at a lower temperature (23-30°C), some of the mutant protein does appear in its 
fully glycosylated form in the cell membrane (Denning et al., 1992a). Reports of whether 
CFTRAF508 that is properly processed retains its ability to regulate chloride conductance 
vary from a form with activity reduced by one third (Denning et al., 1992b) to one with 
normal activity (Li et al., 1993). If CFTRAF508 does represent a potentially normally 
functioning chloride channel, than efforts aimed at correcting abnormal trafficking of the 
mutant protein or, alternatively, of augmenting conductance of channels that do reach the 
membrane, could prove to be of high therapeutic yield. 
Class 3 Defective Regulation: A disproportionate number of missense mutations 
have been reported in the nucleotide binding domains of CFTR. When mutations occur 
that disrupt binding and/or hydrolysis of ATP, cells produce CFTR with an absolute 
reduction in function or with a requirement for higher concentrations of ATP to be 
effective (Anderson and Welsh, 1992). Mutations have also been noted in the regulatory 
domain, but these appear less frequent than in the nucleotide binding domains, perhaps 
because there are multiple degenerate phosphorylation sites in the R domain. Any single 
phosphorylation site mutation does not cause lack of function (See Section 1-3.1.2.). 
Class 4 Defective Conduction: The transmembrane domain is responsible for the 
ion specificity of CFTR. Mutations in this domain produce CFTR in which the protein is 
properly processed, appears in the apical membrane, and, in fact, does generate cAMP- 
dependent chloride currents. In all three documented mutations of this type macroscopic 
current properties resembled those of normal CFTR, but the single channel conductance 
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was reduced. The resulting total amount of current was therefore diminished (Sheppard 
et al., 1993). 
The fundamental disorder of the mutant CF gene is the lack of production or 
mislocalization of a normal-functioning CFTR protein, which, as described above, 
regulates chloride conductance via PKA-dependent phosphorylation. Consequent 
derangement in chloride ion movement results in an inability to appropriately control 
airway intraluminal fluid, with ever-worsening disruption of mucociliary clearance. 
Impaired clearance permits prolonged exposure to noxious stimuli. Although direct 
measurements of mucociliary clearance in CF patients have yielded data revealing 
retarded, normal, and increased rates of clearance, patients with clinically more severe 
pulmonary disease usually have more substantially impaired mucociliary clearance 
(Sanchis et al., 1973). 
Early investigations revealed a deficiency in VIP innervation of sweat glands in 
patients with CF (Heinz-Erian et al., 1985). Although this data was gathered prior to 
identification of CFTR and knowledge of the primary defect in CF, investigators 
recognized the increase in transepithelial potential difference in both sweat gland ducts 
and respiratory mucosa, and had attributed this to a decrease in epithelial chloride 
permeability (Quinton, 1983). Sweat glands, like respiratory epithelium, are richly 
innervated by the autonomic and NANC nervous systems. As discussed above, VIP is 
known to increase chloride conductance across canine tracheal epithelium. It remains 
unclear whether VIP increases chloride conductance through stimulation of CFTR 
chloride channels, through activation of the ORCC, or by means of the paracellular 
pathway. If the absence of VIP innervation of sweat glands reflects a systemic depletion 
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of VIP innervation, then lack of normal stimulation of alternative chloride current routes 
may represent an additional defect in CF that adds to the basic defect in chloride channel 
operation, and, thus, contribute to desiccation of the airways. If VIP innervation of 
airways were intact, then understanding of the mechanism of increased chloride 
conductance via VIP might provide an opportunity for luminal fluid modification. 
The clinical course between the initial genetic defect and the evolution of 
irreversibly damaged lungs is characterized by recurrent suppurative infections instigated 
by Pseudomonas colonization. Patients exhibit a profound inflammatory response which 
is self-propagating: neutrophil elastase, released in response to Pseudomonas, destroys 
key opsonins, such as IgG and C3bi, as well as opsonic receptors on the surface of 
macrophages (Davis et al., 1996). Elastase also stimulates neutrophil chemoattractants, 
including LTB4 and IL-8, increases mucus secretion, and causes structural airway 
damage (Bruce et al., 1985)(Nakamura et al., 1992). Additional data demonstrates that 
certain strains of Pseudomonas express phospholipase C, a hemolysin which directly 
induces an inflammatory response when injected into mice. The response is mediated by 
an increase in inflammatory cells, plasma protein, and the concentration of both 
arachidonic acid metabolites (LTB4, LTC4, LTD4, LTE4) and cyclooxygenase products 
(PGF2a, TXB2) (Meyers and Berk, 1990). This data, combined with previous work 
showing the presence of antibodies to phospholipase C in 100% of CF patients, may 
explain the chronic inflammation present in CF patients (Granstrom et al., 1984). The 
constitutive release of cytokines induced by leukocytes and Pseudomonas products was 
recently confirmed, although the heightened cytokine levels were not ascribed to the 
CFTR protein defect itself (Bedard et al., 1993). 
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It has been proposed that the fundamental interference with mucociliary clearance 
is the determining factor in the ultimate colonization with Pseudomonas. However, 
consistent colonization with Pseudomonas in CF patients amidst variability in 
mucociliary clearance across CF patients draws into question the causality of a reduced 
clearance. Moreover, while post-infection involvement of elastase and the clear response 
to Pseudomonas products may explain the chronic inflammation observed in these 
patients, there remains a gap in understanding why these patients are prone specifically to 
pseudomonal infection. Some researches speculate an increased adherence of 
Pseudomonas to CF epithelium (Zar et al., 1995). Other research suggests that the 
inflammatory response is itself an integral part of CF, and may predate an intensification 
of and predispose to infection. Bronchoalveolar lavage fluid from CF infants reveals an 
increase in neutrophils and IL-8, without evidence of intercurrent infection (Khan et al., 
1995). Likewise, lipid mediators — leukotrienes and prostaglandins — have long been 
identified in CF sputum, yet treatment with antibiotics does not always decrease 
eicosanoid levels in sputum and other respiratory fluid (Zakrzewski et al., 1987). 
Recent investigation suggests that airway epithelia secrete a bactericidal substance 
into the fluid bathing the apical surface which depends on low NaCl concentration to 
function properly. CF patients have a high chloride concentration on affected epithelial 
surfaces secondary to loss of CFTR chloride channels. This research demonstrated that 
typical CF pathogens were killed when added to normal epithelia. Moreover, when the 
NaCl concentration bathing CF epithelia was lowered from its pathologic level, 
Pseudomonas was killed (Smith et al., 1996). The authors suggest therefore that the 
abnormality in sodium and chloride transport not merely affects host defenses by 
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impairing mucociliary clearance, but more fundamentally alters the host’s primary 
chemical defense. This line of reasoning requires a model in which respiratory 
epithelium is a chloride absorbing, rather than a chloride secreting epithelium, which is in 
conflict with the larger body of CF research. Of particular concern in evaluation of this 
argument is how the luminal concentration of NaCl could become so large (124-249mM), 
given that respiratory epithelium is not considered to be a leaky barrier. That is, even in 
the absence of postulated absorptive CFTR chloride channels, how could the luminal 
chloride concentration become hypertonic to the plasma? 
While these various arguments each has appealing qualities, none fully clarifies 
how sodium and chloride ion channels work precisely, or how abnormalities in this 
function coalesce to create the clinical picture of CF. Nevertheless, all agree that there is 
a baseline dysregulation of chloride movement, secondary to mutation of the CFTR 
protein. Understanding more about the structure of this protein, the various channels it 
may regulate, and means to manipulate the CFTR gene product through pharmacologic 
modulation is essential both to resolving these conflicting data and to providing useful 
therapies for those afflicted with CF. 
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2. Statement of Purpose 
The objective of this study was to employ electrophysiological techniques (cell- 
attached and excised inside-out patch clamping) to describe the effects of a specific 
inflammatory mediator, vasoactive intestinal peptide (VIP), on chloride conductance in 
cultured airway epithelial cells. The following questions were addressed in this study: 
1) Does pretreatment of cultured airway epithelial cells with VIP result in 
increased chloride conductance in the cell-attached or excised inside-out patch? 
2) Does VIP increase chloride conductance through a transcellular or paracellular 
pathway? 
3) Is there a statistically significant difference in VIP-stimulated chloride 
conductance in airway epithelial cells from a cystic fibrosis patient (IB3-1 cell line) and 
in “complemented” cells (S9 cell line)? 
4) Are the functional characteristics of observed channel activity consistent with 
previously described apical chloride channel types, specifically, the cystic fibrosis 
transmembrane conductance regulator (CFTR) chloride channel or the outwardly 
rectifying chloride channel (ORCC)? 
5) What are possible cellular mechanisms of observed increases in chloride 
conductance after pretreatment with VIP? 
6) What is the potential therapeutic value of VIP in airway disease? 
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3. Methods 
3-1. Patch Clamp Technique 
3-1.1. Theory and Configurations 
Patch clamp technique was initially conceived of to permit isolation and 
characterization of currents flowing through single channels in the membrane of cells. 
Continued efforts have resulted in refined techniques and equipment that permit 
increasingly higher resolution of channels and advanced manipulation of the environment 
surrounding the cells to be studied. These improvements have made it possible to study a 
wide variety of cell types. 
Patch clamp experiments are a specific type of voltage clamp experiment, that is, 
one controls the voltage and measures the transmembrane current required to maintain 
that voltage. Provided that no other parameters influence physiologic functioning of the 
cell, examining cell membranes under conditions in which the voltage is controlled 
allows determination of the effect of shifts in voltage and evaluation of the effect of any 
specific mediator if the voltage is held constant. The opening and closing, or “gating” of a 
channel can be quantified by measuring the time a channel conducts. Conductance, 
measured as change in single channel current for a small change in membrane voltage, is 
roughly constant for a given channel type (Corey, 1983). Units are in amperes per volt, 
or siemens (S). 
Currents are observed and recorded by placing a glass micropipette flush against 
the external membrane of the cell to be studied. The current recorded is the current 
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flowing across the membrane encircled by the tip of the micropipette. Because the cross- 
sectional area at the tip of the pipette is so small, the probability that there is only one or 
two channels in the patch of membrane being recorded is high. 
Patch clamp configurations are designated by the orientation of the membrane in 
relation to the micropipette, and this configuration determines whether the applied 
voltage is hyperpolarizing or depolarizing (Sherman-Gold, 1993). There are four basic 
configurations for clamping: cell-attached, inside-out, whole cell, and outside-out 
(Figure 3). Each has advantages and disadvantages; the type used for a given experiment 
is determined by the type of cell and channel being studied. 
In cell-attached patches the membrane patch remains attached to the cell, with the 
pipette tip connected to the outside surface of the membrane. In this case, a positive 
command voltage (Vcom) causes the transmembrane potential (Vmem) to become more 
negative, and thus is hyperpolarizing. This configuration is least disturbing to the 
structure and internal milieu of the cell. While this may be beneficial for obtaining the 
most physiologic data, it limits manipulations one may make. The inner membrane faces 
the cytoplasm of the cell, which one cannot control. Moreover, to measure the resting 
intracellular potential, one must insert a separate voltage-measuring electrode. 
An inside-out patch is created when the pipette is retracted from the surface of the 
cell suddenly after a seal is achieved; the surface that was originally the inner membrane 
is then exposed to the bath solution, while the previously external membrane now faces 
the inside of the pipette. Thus the potential on the true inside surface is OmV, the bath 
potential. The transmembrane voltage can be known exactly. In this case, a positive 
command voltage causes the transmembrane potential to become more negative, and thus 
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Low resistance seal 
Gigaohm seal 
CELL ATTACHED 
WHOLE CELL OUTSIDE-OUT INSIDE-OUT 
RECORDING PATCH PATCH 
Figure 3. Four patch clamp configurations. This is a schematic illustration of four 
different patch clamp configurations and the manipulations that lead to them. Please see 
text for details. Adapted from Hamill, et ah, 1981. 
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is hyperpolarizing. A key advantage to the inside-out patch is the unlimited access one 
has to the cytoplasmic surface of the membrane: during the course of an experiment one 
may change the concentration of any mediator or ionic consituent without disrupting the 
integrity of the membrane. The primary disadvantage to this configuration is that the 
patch has a propensity to seal over and form a vesicle, which obstructs access to the inner 
surface of the membrane and can alter current flow. The risk of vesicle formation can be 
minimized by using a bath solution with micromolar calcium concentration, which can be 
achieved by the addition of chelators such as EGTA (Corey, 1983). If a vesicle does 
form, it can sometimes be broken by briefly withdrawing the pipette from solution. 
Inside-out patch clamping was the sole configuration employed in these experiments. 
In a whole-cell patch, the membrane remains attached to the cell, but a brief pulse 
of suction results in rupture of the membrane just inside the rim of the pipette. This 
configuration is similar to impaling a cell with a microelectrode, but produces good 
recordings on very small cells (Sakmann and Neher, 1984). In whole-cell patches, the 
average activity of all channels in the patch is measured, rather than that of individual 
channels. Thus, this method is useful when the conductance of a given channel is too 
small to be measured as a single event (Corey, 1983). 
An outside-out patch is derived from a whole-cell patch by slowly withdrawing 
the pipette, thereby pulling a tube of membrane away from the cell until the portion of 
membrane pinches off. The membrane patch is detached from the cell such that the 
surface that was the outside of the cell remains exposed to the bath solution, and retains 
its original OmV potential. As the inverse of the inside-out configuration, the advantage 
lies in being able to alter the ionic, hormonal, or neurotransmitter environment on the 
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outer surface of the membrane. Outside-out patches are also less likely to form vesicles 
(Corey, 1983). In an outside-out patch, a positive command voltage causes the 
transmembrane potential to become less negative, and, hence, is depolarizing. 
3-1.2. Micropipettes 
Patch clamp microelectrodes consist of an AgCl-coated Ag wire placed in a 
solution-filled glass micropipette, which serves as the reservoir for the conducting 
solution and the means of connection to the cell membrane. Early problems in patch 
clamping centered on obtaining and maintaining an adequate seal between the edges of 
the pipette and the cell. Adequacy of the seal depends on the resistance obtained. When 
high seal resistance is achieved, a greater fraction of the membrane current flows into the 
pipette rather than leaking out. If there is not a tight adherence between the membrane 
and the glass of the pipette, current can leak into the extracellular solution, which 
adversely affects recordings obtained: 1) current lost through leakage will not be 
measured; 2) thermal movement of charges through the conducting solution will result 
in increased noise in the recording (Sherman-Gold, 1993). Thus, a high resistance seal is 
essential to minimize undetected current and to produce low-noise recordings. Such a 
seal is referred to as a “gigaseal,” and is defined as a sudden increase in seal resistance by 
as much as three orders of magnitude (Hamill et al., 1981). When a gigaseal is formed, 
noise due to current leakage becomes minimal; other sources of noise, including that 
from electronics and the micropipette glass, become the limiting factors in recording 
resolution. The two main criteria for achieving gigaseals are use of filtered solutions in 
the bath and the pipette, and use of a fresh pipette for each seal (Hamill et ah, 1981). 
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Obtaining gigaseals consistently requires that one use clean, freshly fabricated 
glass micropipettes, and that they only be used once. Manufacture of pipettes entails a 
three step procedure: pulling of the pipette, coating of the shaft with a hydrophobic 
substance, and heat polishing of the tip (Hamill et ah, 1981). Pipette fabrication 
equipment includes a Narishige (Tokyo, Japan) PP83 puller and MF-83 microforge. 
Glass capillary tubes that are appropriate for the production of micropipettes have walls 
of substantial thickness (0.2-0.3mm), which generates less electrical noise and increases 
bluntness at the tip, thereby reducing the possibility of cell penetration during seal 
formation (Sherman-Gold, 1993). Gamer glass micro-hematocrit capillary tubing 
(Borosilicate, Kimax KG-33 and Coming 7052), with an inside diameter of 1.05mm and 
an outside diameter of 1.5mm, is pulled using a two step process in order to ensure a 
suitably blunt tip. In addition to wall thickness, three features of the glass used to fashion 
pipettes contribute to the quality of the recordings obtained: the temperature at which the 
glass softens, the electrical properties of the glass, and the major chemical constituents of 
the glass (Sherman-Gold, 1993). Glasses that soften at low temperatures produce a 
blunter tip than glasses that soften at higher temperatures. Borosilicate capillary tubing 
softens at 821°-830°C. The dielectric properties of a particular glass are described by its 
“loss factor;” glasses with the lowest loss factor exhibit the lowest noise. Finally, glass 
made of components with a tendency to leach into the surrounding solution can 
unfavorably alter the currents observed. 
To minimize noise resulting from solution creeping up the outer walls of the 
pipettes, the shafts of the pulled pipettes are coated with a hydrophobic compound, 
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Sylgard (Dow Coming, Belgium). Ideally, pipettes are coated to within 100pm of the tip, 
and then cured by passing the tip within a heated metal coil. However, this procedure 
was not performed with the latter half of experiments in this study, and appeared to make 
no difference in the data obtained. An optimally blunt tip is obtained by firepolishing the 
pipette tip. 
3-1.3. Channel Recording and Analysis 
Data is acquired using the Axopatch 200 integrating patch clamp and the 
Pclamp6\TL-l data acquisition and analysis system. Data are digitalized (Sony PCM-601 
ESDI audio processor) and stored on either Sony T120PR or Maxel T120P/I Plus 
professional grade VHS videotape. Channel data is viewed on an oscilloscope (Nicolet 
300). 
Recordings are transferred to computer (Gateway 486 computer) in 20 second 
sweeps in digitalized form by either an Axopatch TL-1 or a Digidata 1200 interface. 
Digitalized files are analyzed using Pclamp6 software (Axon Instruments, Burlingame, 
CA). All recordings are analyzed at a filter frequency of 300 Hz. Pclamp6 software was 
used to determine mean channel amplitude for each 20 second sweep. A Marquardt Least 
Squares fit was employed to determine mean amplitude. 
Mean current for each voltage level was determined by Sigmaplot software. I-V 
plots were generated, and linear regression of the resulting plot yielded a line, the slope of 
which equals the mean current of all channels observed. 
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3-2. Tissue Culture 
Three cell lines, each with specifically chosen and constructed properties, were 
used in these experiments. The IB3-1 cell line consists of clonal descendants taken from 
a cystic fibrosis-affected child, and thus lacks normal functioning CFTR protein. The S-9 
cell line is the IB3-1 cell line transfected with wild type CFTR. The FHTE cell line is 
obtained from normal fetal human tracheal epithelium. Each of these cell lines were 
obtained from Dr. William Guggino at Johns Hopkins University. Dr. Marie E. Egan is 
presently culturing these cell lines at Yale University School of Medicine. 
Tissue culture techniques employed consist of growing cells in T75 flasks coated 
with a mixture of distilled water, fibronectin (10pg)/bovine serum albumin 
(BSA)(100pg)/collagen (6mg/ml) and maintained in a 5% C02/95% air incubator at 
37°C. Growth media, LHC-8 supplemented with penicillin (100pg/ml), streptomycin 
(lOOpg /ml), tobramycin (80pg/ml), 5% fetal calf serum, and endothelial cell growth 
factor (25pg/ml), is changed three times a week. Prior to patch clamp studies, cells are 
passaged onto glass chips coated with fibronectin, BSA, and collagen as described above. 
They are maintained as described above, and are studied optimally 2 days after passage. 
3-2.1. IB3-1 Cell Line 
The IB3-1 cell line was created to permit detailed investigation of the specific 
genetic defect known to lie behind the lethal disease cystic fibrosis. Zeitlin, et al., used 
bronchial epithelium from a patient with CF to establish this immortalized cell line 
(Zeitlin et al., 1991). They infected cells with AD-12-SV40, a hybrid of adenovirus 12 
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(AD-12) and simian virus 40 (SV40), which had been used successfully in previous 
efforts to transform human epithelial cells (Rhim et al., 1985). These earlier studies with 
AD-12-SV40 had shown that the virus induces mRNA from the transforming region of 
SV40 during transformation. Moreover, it has been shown not to be tumorigenic. 
Bronchial epithelial cells were gathered from the airways of a 7-year-old white 
male child determined to have CF by sweat chloride test and the presence of severe 
obstructive pulmonary disease accompanied by colonization with Pseudomonas 
aeruginosa. The primary cells (CFBE) were maintained in a mixture consisting of 
medium supplemented with endothelial cell growth supplement and antibiotics. The 
CFBE cells were infected with an AD-12-SV40 hybrid after the primary culture reached 
80% confluence. Within 4 to 6 weeks, clusters of clonal growth were apparent. At 
passage 12, CFBE cells were diluted and plated, and, after screening and selection of only 
those cells that were non-producers of virus, the clone IB3-1 was cloned a second time. 
Radioimmunoassay quantitation of cAMP, genetic analysis, and patch clamp 
analysis studies were performed to determine the characteristics of the final IB3-1 clone. 
Five criteria were used to judge suitability of this cell line as representative of CF 
epithelia: 
1. The cells must consistently demonstrate abnormal chloride permeability in the 
apical membrane and failure of stimulation of chloride conductance by B-adrenergic 
agonists; 
2. B-agonist stimulation should increase intracellular cAMP; 
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3. the secretory chloride channel should open with depolarizing voltages, but not 
in response to phosphorylating agents (e.g. PKA); 
4. the DNA must contain the mutant CF gene; 
5. long-term propagation of cells in culture must be possible without loss of 
phenotype. 
The final IB3-1 clone satisfied all of these requirements. Of note, the patient from 
whom the CFBE were harvested was not homozygous for the most common CF 
mutation, AF508. These cells are genotypically AF508/W1282X at the CFTR locus. The 
W1282X mutation creates a premature stop codon, producing an unstable message and no 
CFTR protein. Thus, unlike previous cell lines which only conveyed information about 
epithelial cell characteristics in the presence of homozygous mutations, this cell line 
provides information regarding the effects of alternate mutations on chloride 
conductance. 
3-2.2. S9 Cell Line 
The S9 cell line is the IB3-1 cell line transfected with the wild-type CFTR gene. 
With this configuration, data obtained from similar experiments on the two cell lines 
permits correlation of the effect of experimental manipulations on the S9 cells 
specifically with the presence of a normal functioning CFTR-associated chloride channel. 
By creating the “normal” cell line from the defective one, the presence of confounding 
differences in other aspects of cell function is eliminated. 
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Flotte, et al., used an adeno-associated vims (AAV) vector to transfect the full 
length CFTR cDNA, and demonstrated restoration of cAMP regulation of chloride 
conduction ascribed to proper CFTR functioning (Flotte et al., 1993). AAV vectors 
consisting of a p5 transcription promoter and the AAV inverted terminal repeat (ITR) 
were used in the development of the IB3-1 line. However, the packaging parameters of 
foreign DNA limit its use when the material to be transfected is a large gene, such as 
CFTR. Flotte et al., recognized that the AAV ITR was able to function directly as a 
transcription promoter. CFTR cDNA with an amino-terminal deletion, expressed via an 
AAV ITR promoter, effectively complemented the CF defect in the IB3-1 cell line. 
Cells were tested for functional expression of CFTR by examining the response to 
forskolin via chloride efflux assays. To correlate the appearance of cAMP-associated 
increases in chloride conductance with expression of CFTR protein, cells were stained 
with anti-CFTR antibodies and examined via immunofluorescence. Results demonstrated 
that only cells treated with AAV vectors expressing functional CFTR protein stained 
significantly in the immunofluorescence assay. Finally, Southern blot analysis confirmed 
the presence of replicating forms of AAV-CFTR vector DNA in all cells treated with 
vectors. 
3-2.3. FHTE Cell Line 
The FHTE cell line was created by Gruenert, et.al., as an object for detailed 
studies of the mechanisms of normal epithelial chloride ion transport (Gruenert et al., 
1988). Cells were isolated from human fetal trachea. A plasmid consisting of the simian 
virus 40 (SV40) genome which was defective in the origin of replication (pSVori-) was 
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chosen because this deficiency had previously been demonstrated to enhance 
transformation in human fibroblasts. Although transformed cells experience a change in 
phenotype, epithelial cells retain important aspects of the original phenotype after 
transformation crisis, including responsiveness to neural agonists (e.g., B-adrenergic 
agonists), keratin production, and chloride ion transport. 
The residual phenotypic characteristics of these cells were used to assess success 
in obtaining an immortalized cell line suitable for experimentation. All cell lines tested 
expressed immunoreactivity to keratin in both pre- and post-crisis stages. Cells were 
exposed to the B-adrenergic agonist, isoproterenol, to determine whether the cells 
retained the second messenger cascade involving cAMP. Stimulation with 10'5M 
isoproterenol led to an accumulation of cAMP. 
Of note, although the respiratory epithelium is a primary site of cystic fibrosis, 
studies have demonstrated that CF lung is normal in utero, even when disease is present 
in the intestine, vas deferens, pancreas, and liver (Sturgess and Imrie, 1982). This 
suggests that the fetal tracheal chloride channel may operate under different regulation 
than the adult respiratory epithelial chloride channel. The lack of disease in the fetal lung 
is surprising, given the plethora of CFTR activity present before birth (McCray, Jr. et al., 
1992). If the fetal lung does have alternative chloride channel stimulation mechanisms, 
then the FHTE cell line may not be optimal for study of CFTR properties. 
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3-3. Protocol 
Patch clamp experiments were performed using cell-attached and excised inside- 
out membrane patches from normal (FHTE), CF-affected (IB3-1) and CFTR-transfected 
(S9) cell lines. All experiments were conducted at 25-30°C. Bath solution was changed 
between each experiment with a 5mL flush. Of 25 experiments included in this report 
regarding the effect of VIP, each represents data obtained from the cell-attached and 
excised membrane of a distinct epithelial cell. 
All cells are pretreated with lpM VIP for ten minutes prior to seal formation. 
Cells are visualized with a Nikon Diaphot phase contrast microscope which is mounted 
on a Newport anti-vibration airtable to minimize turbulence. A fresh clean flint glass 
micropipette for each patch attempt is positioned by means of a Newport 
micromanipulator. A cell attached configuration is achieved by gently pressing the patch 
electrode against the cell membrane of the intact cell. Application of negative pressure 
generated by withdrawal of a lOmL syringe provokes development of a high resistance 
seal. After gigaseal formation, patches are observed in the cell-attached position. 
Membrane potential is varied using Pclamp software (Axon Instruments, Burlingame, 
CA) in lOmV steps from +80mV to -80mV, beginning at +40mV and moving 
sequentially outward toward +80mV. Patches are then excised by retracting the pipette 
briskly from the cell to obtain inside-out patches. Membrane potential is again varied in 
a stepwise fashion. 
During recording of excised patches, each patch is observed for rundown in 
channel activity representative of depletion of ATP from the bath solution. If rundown is 
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noted, exchange of pure bath solution with bath solution containing ATP (ImM) is 
attempted with maintenance of the seal. 
Solutions and Chemicals 
Bath Solution: 150mM NaCl, 2mMMgCl2, ImM EGTA, 5mM Hepes, 0.5 mM CaCl, 
Pipette Solution: 150mM NaCl, 2mM CaCl2, 5mM Hepes 
The pH of each solution was adjusted to 7.3 with Tris base. All solutions were 
filtered at the time of use with a Millipore 0.22 filter. 
Synthetic porcine VIP was suspended in standard bath solution to make a stock 
solution (ImM). The stock solution was frozen until the day of use. A lpM solution was 
made by adding 40pl of stock solution to 40mL of standard bath solution. VIP was 
obtained from Sigma Chemical Co. (St. Louis, MO), product number V3628. 
The magnesium salt of ATP was dissolved in standard bath solution to a final 
concentration of ImM. The pH of the solution was adjusted to 7.4. ATP solution was 
kept on ice between experiments; remaining ATP solution was frozen for up to one 
week. ATP was obtained from Sigma Chemical Co. (St. Louis, MO), product number A- 
9183. 
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4. Results 
4-1. FHTE Cell Line 
Although initial experiments were conducted with the FHTE cell line, difficulties 
with maintaining the cells and with patching them prompted continuation of the study 
with the IB3-1 and S9 cell lines. FHTE cells did not consistently reach confluence in a 
specified time period and were prone to contamination. Cells that appeared amenable to 
experimentation proved to be fragile and did not seal reliably. Preliminary data from 
experiments conducted with FHTE is similar to data presented here for S9 cells. 
However, the tracings were brief and problematic to analyze due to electrical noise. 
Thus, FHTE data is not documented in this report. All of the analyzed data is derived 
from experiments involving the IB3-1 and S9 cell lines. 
4-2. IB3-1 Cell Line 
A gigaseal was successfully obtained and held in thirteen patches of IB3-1 cells. 
Each of these cells had been pretreated with lpM VIP solution for ten minutes prior to 
seal formation. Patches were first observed in the cell-attached mode. Voltage potential 
was initially held at ±40 mV, with recording of the corresponding oscilloscope image 
made at lOmV increments up to ±80 mV. After channel activity, or the lack thereof, had 
been documented at each level, the patch was excised, and again exposed to holding 
potentials ranging from ±40 mV to ±80 mV. Of the thirteen patches in which a gigaseal 
was attained and recordings made in the cell-attached mode, eleven were excised with 
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maintenance of a non-leaky seal. Patches in which electrical noise or a poor seal 
interfered substantially with possible interpretation of oscilloscope deflections were 
terminated prior to completion of the protocol (Table 2). 
4-2.1. Presence of ORCC-Like Channel in IB3-1 Cell Line 
Nine of the thirteen patches (69%) were silent patches, demonstrating no channel 
activity detectable grossly or by analysis with the Pclamp6 program. Although very 
small channels may have been present, activity was not sufficient to be resolvable by the 
methods employed. However, the remaining four patches did demonstrate a large 
outwardly rectifying chloride current. Importantly, this channel was only apparent after 
the patch had initially been exposed to a depolarizing voltage of at least +70mV. Visual 
inspection of the amplitude of the channels present in these four (31%) remaining patches 
suggests that these channels are not CFTR chloride channels. The amplitude, mechanism 
of activation, behavior after excision, and response to addition of ATP suggests that 
deflections observed in these active patches represent ORCC events (Figure 4). 
Channels present in these four patches had a large amplitude consistent with the 
reported conductance of 20-30pS for ORCC channels. Moreover, the requirement of a 
depolarizing voltage of at least +70 mV to activate the channel in each of the four patches 
also supports the identification of this large channel as ORCC. Of note, this channel 
remained active at lower voltages after the initial large depolarizing voltage (Figure 5). 
In addition, unlike CFTR channel activity which reliably decreases after excision due to a 
requirement for a renewable supply of ATP to maintain channel activity, none of the four 
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Table 2 
Summary of Data Involving IB3-1 Cell Line 
Totals 
Number of patches 13 
Number of patches without chloride channel activity 9 
Number of patches with chloride channel activity 4 
Percent of patches with any channel activity 31% 
Number of patches with other channel activity 4 
Number of patches pretreated with VIP 13 | 
Number of patches pretreated with VIP demonstrating 
chloride channel activity 
4 
Of Patches Demonstrating Chloride Channel Activity (n=4) 
Channel activity observed in cell-attached mode 3 
Channel activity observed in excised mode 3 
Rundown evident after patch excision 0 
Number of patches treated with ATP 3 ! 
Number of patches treated with ATP demonstrating change 
in channel activity 
0 
Number of patches demonstrating possible ORCC 4 
Percent of patches demonstrating possible ORCC 31% 
Note: Previous studies of IB3-1 cells conducted in the absence of VIP demonstrate 
activation of ORCC only with large depolarizing voltages. No chloride 
conductance was apparent after manipulation of PKA-regulated mechanisms 
(Personal communication with Marie E. Egan, M.D.)(Egan, et al., 1992)(Egan, et 
ah, 1995). 

62 
Cell-attached at Vcom=-60mV, after pretreatment with lpM VIP for 10 minutes 
4W **** 
Excised at Vcom=-60mV 
> 
1 minute after ImM ATP addition, Vcom=-60rnV 
Vcom=-60mV, after activation by Vcom=+80rnV 
2pA 
100ms 
Figure 4. Chloride channels in CF airway epithelial cells (IB3-1). Cells from the 
IB3-1 cell line were pretreated with lpM VIP for 10 minutes prior to seal formation. The 
failure of VIP activation of chloride channels in this patch was monitored for 5 minutes in 
both the cell attached and excised modes. Addition of ImM ATP to the cytoplasmic 
aspect of the membrane after excision failed to elicit chloride channel activity. Outwardly 
rectifying chloride channels were observed after activation by depolarizing voltage. Vcom 
is holding potential. Vmem equals -Vcom. Upward deflection represents chloride channel 
opening. Arrows indicate the closed state. Data were digitized at 1kHz and filtered for 
display at 500Hz. Please note scale where 8mm=2pA. 
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Vcom=+40mV, after pretreatment with lpM VIP and excision 
VCOm=+40mV, after activation by +80mV 
2pA 
100ms 
Figure 5: Outwardly rectifying chloride channel at low voltage in CF airway 
epithelial cells (IB3-1). Cells from the IB3-1 cell line were pretreated with IpM VIP for 
10 minutes prior to seal formation. Although no channels were apparent in either the 
cell-attached or excised modes initially, activation by depolarizing voltage elicited 
outwardly rectifying chloride channel activity. This channel remained active at voltages 
of +40 mV or less. Vcom is holding potential. Vmem equals -Vcom. Downward deflection 
represents chloride channel opening. Arrows indicate the closed state. Data were 
digitized at 1kHz and filtered for display at 500Hz. Please note scale where 16mm=2pA. 
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patches with evident channels in the IB3-1 cell line demonstrated “rundown” after 
channel excision. 
Application of ImM ATP to the solution bathing patches (n=3) that demonstrated 
no channel activity did not effect any change in apical current. This tactic is often 
successful in “reviving” CFTR channel activity in patches that have rundown after 
excision. However, as demonstrated in Figure 4, addition of ATP to the bath solution of 
the IB3-1 cell line brought about no perceptible difference in activity level compared with 
prestimulation levels. 
4-2.2. Presence of Nonspecific Cation Channel in IB3-1 Cell Line 
In four of thirteen patches (31%) a rare small conductance channel was observed 
which appeared to be consistent with a nonspecific cation channel (Figure 6). Within this 
cell type, as well as in other epithelial cell lines, a nonspecific cation channel ranging 
from 10-20pS has been reported previously, as has a smaller cation conductance (5-1 OpS) 
activated by stretch. It is unlikely that this channel represents a CFTR chloride channel, 
given its generally lower mean conductance, and the apparent lack of ATP or PKA 
dependence. However, because ionic substitution experiments were not performed, the 
precise nature of this observed channel remains uncertain. 
4-3. S9 Cell Line 
A gigaseal was successfully obtained and held in twelve patches of the S9 cell 
line, which was created by transfecting the IB3-1 line with wild-type CFTR. Each of 
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Excised at Vcom=+50mV 
2pA 
100ms 
Figure 6: Presence of low conductance channel in CF airway epithelial cells (IB3-1). 
Cells from the IB3-1 cell line were pretreated with lpM VIP for 10 minutes prior to seal 
formation. Rare channel openings were observed in the excised mode in four patches. 
Vcom is holding potential. Vmem equals -Vcom. Downward deflection represents channel 
opening. Arrows indicate the closed state. Data were digitized at 1kHz and filtered for 
display at 300Hz. Please note scale where 16mm=2pA. 
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these cells had been pretreated with lpM VIP solution for ten minutes prior to seal 
formation. In contrast to the IB3-1 cells, ten of these twelve patches (83%) demonstrated 
channel activity and two were silent patches. Like patches from the IB3-1 line, patches 
underwent examination throughout the spectrum of holding potentials in both the cell- 
attached and excised modes. All of the ten patches demonstrated activity in both the 
cell-attached and excised modes (Table 3). 
4-3.1. Presence of CFTR-Like Channel in S9 Cell Line 
Unlike the IB3-1 cell line, patches from S9 cells revealed channels with functional 
characteristics representative of CFTR chloride channels. The mean conductance of the 
channels observed in these ten samples, calculated from the slope of the linear regression 
obtained from plotting mean current versus potential (Figure 7), is 10.4pS±0.39pS, which 
is consistent with the expected conductance reported for CFTR of 8-10pS. Also, as 
predicted for CFTR, channel activity ran down after patch excision in eight patches 
(80%) initially displaying oscilloscope deflections (Figure 8). In the two remaining 
active patches in which rundown was not documented, the seal broke after channel 
activity similar to that present in the other eight patches was observed, but before 
rundown occurred. It is likely that these channels also would have exhibited a decrease in 
activity had the seal of the patch remained stable. 
Moreover, in the patches exhibiting rundown after excision, 75% (3/4) of patches 
treated with ImM ATP demonstrated a burst of channel activity within three minutes of 
addition of ATP, which is consistent with CFTR chloride channels (Figure 8). 
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Table 3 
Summary of Data Involving S9 Cell Line 
Totals 
Number of patches 12 
Number of blank patches 2 
Percent of patches with channel activity 83% 
Number of patches pretreated with VIP 12 
Number of patches pretreated with VIP demonstrating 
channel activity 
10 
Of Patches Demonstrating Chloride Channel Activity (n=10) 
Channel activity observed in cell-attached mode 8 
Channel activity observed in excised mode 10 
Rundown evident after patch excision 8 
Number of patches treated with ATP after rundown 4 
Number of patches treated with ATP demonstrating 
restoration of channel activity 
3 
Number of patches demonstrating possible ORCC 5 
Percent of patches demonstrating possible ORCC 50% 
Note: Previous studies of S9 cells conducted in the absence of VIP demonstrate 
that CFTR chloride channel activity is seen only when cells are stimulated with 
agents that increase cAMP (forskolin, IBMX) or when excised patches are exposed 
to PKA and ATP. ORCC is activated either by PKA and ATP addition or by large 
depolarizing voltages (Personal communication with Marie E. Egan, M.D.)(Egan, et 
al., 1992)(Egan, etal., 1995). 
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Figure 7. I-V relationship of low conductance channels in S9 cells pretreated with 
VIP. This figure demonstrates the I-V relationship for low conductance channels in 
excised inside-out patches bathed in symmetrical chloride solutions [01],= [Cl']0 = 
150mM (n=10). Patches were excised from S9 cells pretreated with lpM VIP. The I-V 
relationship was linear over the voltage range studied. The mean conductance was 
10.4pS ±0.39pS. The solid line represents a linear regression fit to the data. 
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Excised at Vcom=+70mV, after pretreatment with lpM VIP 
5 minutes after excision, Vcom=+70mV 
1 minute after ImM ATP addition, Vcom=+70rnV 
2pA 
100ms 
Figure 8: Activation of low conductance chloride channel in “complemented” IB3-1 
cells (S9). Cells were pretreated with lpM VIP for 10 minutes prior to seal formation. 
Initially, low conductance channel activity is observed. Rundown of low conductance 
chloride channel occurred within 5 minutes of patch excision. Addition of ImM ATP to 
the cytoplasmic surface of the patch resulted in restoration of low conductance channel 
activity. Vcom is holding potential. Vmem equals -Vcom. Downward deflection represents 
chloride channel opening. Arrows indicate the closed state. Data were digitized at 1kHz 
and filtered for display at 500Hz. Please note scale where 8mm=2pA. 
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4-3.2. Presence of ORCC-Like Channel in S9 Cell Line 
In addition to the smaller, presumed CFTR chloride channel, five of ten (50%) 
patches exhibited a larger channel suggestive of ORCC (Figure 9). Moreover, eruption of 
activity invariably coincided with instigation of a high depolarizing voltage of at least 
+70mV. These channels were not present at voltages less than ±70mV unless the patch 
had first been exposed to a depolarizing voltage greater than or equal to +70mV. This 
channel did not demonstrate rundown in any of the five patches, and thus, the affect of 
added ATP on ORCC activity was not specifically investigated. However, addition of 
ATP (ImM) following rundown of the small conductance channel did not result in a 
concurrent increase in ORCC activity. 
4-3.3. Patches Without Channels in S9 Cell Line 
Two of the total twelve patches were silent. Channel activity was absent in both 
the cell attached and excised modes, and did not appear with ATP addition or 
depolarization (Figure 10). It is likely, therefore, that these two patches contained no 
channels in the cell membrane sampled. 
4-4. Statistical Analysis 
Due to the small sample size of patches analyzed for each cell line, the Fischer 
exact test was employed to determine the significance of any observed differences 
between cell lines in the presence of channels in the apical membranes. Presence of 
CFTR-like chloride currents in the S9 cell line, but not in the IB3-1 cell line produced a P 
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value of 0.00002. Presence of ORCC-like chloride currents in both the S9 and IB3-1 cell 
lines produced a P value of 0.6882. 
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Vcom=+50mV, after activation by V^^+SOmV 
—'V/AA^rv-nn/'x/^—uuv*r 
2pA 
100ms 
Figure 9: Outwardly rectifying chloride channel in “complemented” IB3-1 cells 
(S9). Cells from the S9 cell line were pretreated with lpM VIP for 10 minutes prior to 
seal formation. In addition to the linear low conductance channel (not demonstrated in 
this figure), a larger outwardly rectifying channel was observed, which was present only 
after activation by depolarizing voltage. VC0]n is holding potential. Vmem equals -Vcom. 
Downward deflection represents channel opening. Arrows indicate the closed state. Data 
were digitized at 1kHz and filtered for display at 500Hz. Please note scale where 
8mm=2pA. 
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Cell-attached at Vcom=+60mV, after pretreatment with lpM VIP for 10 minutes 
Excised at Vcom=+60mV 
1 minute after ImM ATP addition, Vcom=+60mV 
Vcom=+60mV, after activation by Vcom=+80mV 
2pA 
100ms 
Figure 10: Silent patch in “complemented” IB3-1 cells (S9). Cells from the S9 cell 
line were pretreated with lpM VIP for 10 minutes prior to seal formation. The failure of 
VIP activation of chloride channels in this patch was monitored for 5 minutes in both the 
cell-attached and excised modes. Addition of ImM ATP to the cytoplasmic aspect of the 
membrane after excision failed to elicit chloride channel activity. No outwardly 
rectifying chloride channels were observed with depolarizing voltage. Vcom is holding 
potential. Vmem equals -Vcom. Downward deflection represents channel opening. Arrows 
indicate the closed state. Data were digitized at 1kHz and filtered for display at 500Hz. 
Please note scale where 8mm=2pA. 

74 
5. Discussion 
5-1. Effect of VIP on Chloride Conductance in Airway Epithelial Cells 
This study set out to define the mechanism by which VIP increases chloride 
conductance in airway epithelial cells. We postulated that VIP could act via three unique 
mechanisms: indirect stimulation through initiation of a second messenger cascade; 
direct action on chloride channels; or loosening of tight junctions and increase of current 
through a paracellular path (Figure 11). 
A likely pathway included activation of CFTR chloride channels. However, 
although VIP is known to increase cAMP intracellularly and research has demonstrated 
CFTR to be a cAMP-dependent chloride channel, one cannot assume that VIP therefore 
activates CFTR chloride channels through cAMP. As outlined in this paper, several 
apical chloride channels exist in epithelial cells, at least two of which — CFTR chloride 
channels and ORCC — are cAMP-dependent and regulated by CFTR. Characterization of 
the chloride current is a first necessary step in pinpointing the mechanism of VIP current 
activation. A second crucial component in attributing the observed increase to CFTR is 
to demonstrate that an identical current is not observed upon stimulation with VIP in cells 
that do not contain the CFTR chloride channel. This study provides evidence that the 
mechanism of VIP augmentation of chloride current relies on activation of CFTR. 
However, the data does not unequivocally support or contradict the role of cAMP as the 
second messenger involved in transduction of the initiating chemical signal. 
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Cl 2. VIP Cl Cl 4. VIP 
1. VIP 
Key to Symbols: 
VIP receptor G protein Tight junction 
CFTR ORCC 
Figure 11. Possible Mechanisms of VIP Stimulation of Chloride Secretion in 
Airway Epithelia. 
1. VIP activates intracellular cascade, which subsequently activates CFTR chloride 
channels. 
2. VIP acts directly on the extracellular or intracellular aspect to stimulate CFTR 
chloride channels. 
3. VIP activates ORCC either indirectly through initiation of intracellular cascade and 
regulation by CFTR, or directly. 
4. VIP acts indirectly through receptors or directly on the epithelial surface to uncouple 
tight junctions, thus increasing chloride permeability of the layer. 

76 
5-2. VIP Indirectly Activates CFTR Chloride Channels 
Given understanding of the independent mechanisms of VIP and CFTR, one 
possible mechanism of increased apical chloride current involves stimulation of CFTR by 
an increase in cAMP brought about by VIP. Presuming the concentration of VIP was 
sufficient and that VIP properly activated membrane receptors, all S9 cells pretreated 
with VIP experienced an increase in intracellular cAMP. In 83% of patches examined 
from these cells, a 10.4pS±0.39pS current appeared that corresponds in magnitude and 
direction of flow to that expected for chloride currents generated uniquely by CFTR. 
This channel has no intrinsic activity at baseline; that is, CFTR demonstrates no chloride 
current unless it is stimulated by exogenous addition of cAMP or PKA with ATP, or by 
another agent that supports endogenous supply of cAMP from adenyl cyclase, such as 
forskolin, IBMX, or a B-adrenergic agonist. Likewise, VIP is an agent capable of 
increasing cAMP. Thus, a possible scheme might involve VIP-induced generation of 
cAMP, with consequent phosphorylation of CFTR by PKA and increase in apical 
chloride current. 
Such a model in which VIP activates CFTR is bolstered by two other findings 
significant for CFTR-generated chloride flow in S9 cells. First, the small linear chloride 
conductance observed in the cell-attached mode, which has conductance of 
10.4pS±0.39pS when excised, ran down to prestimulation levels upon excision in eight of 
the ten patches with documented channel activity. In CFTR chloride channels, rundown 
after excision occurs in part when the R domain is dephosphorylated by specific 
phosphatases near the detached cell membrane and is not rephosphorylated due to the 
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absence of PKA in the vicinity of the channel. Channel activity is restored by addition of 
the catalytic subunit of PKA and ATP to the bathing solution. A second pertinent finding 
is the restoration of the identified 10.4pS±0.39pS current in three of four patches treated 
with ATP after rundown. Depletion of ATP in the bathing solution after excision is the 
causative factor in channel rundown observed in CFTR channels. Resurgence of the 
previously documented current reflects resupply of nucleotide triphosphate for both 
binding and hydrolysis necessary for channel opening. Other chloride channels 
recognized in the apical membrane of airway epithelial cells do not exhibit this 
characteristic pattern of rundown and restoration of current with ATP addition. 
In addition, the overwhelmingly different response to VIP observed in S9 cells 
compared with IB3-1 cells suggests that VIP does activate a pathway whose end-target is 
stimulation of CFTR. While the small conductance channel appeared in 83% of S9 
patches pretreated with VIP, none of the thirteen IB3-1 cells pretreated with VIP 
manifested a similar channel. This disparity represents a statistically significant 
difference with P=2xl0"5. The only genetic dissimilarity between these two cell lines is 
the presence of CFTR in the S9 cells. In fact, the S9 cell line is derived from the IB3-1 
cell line: cells obtained from a CF-affected boy (IB3-1 cell line) were transfected with 
wild-type CFTR to create the S9 line, the only distinguishing characteristic of which 
would be the presence of the CFTR gene product. 
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5-3. VIP Directly Activates CFTR Chloride Channels 
Another possible pathway is that VIP acts directly on chloride channels without 
an intervening second messenger. While the data on conductance and behavior does 
suggest activation of a CFTR chloride channel, the path of activation could be direct 
rather than indirect. Although VIP demonstrably increases cAMP in cells, activation of a 
second messenger cascade, ostensibly designed to magnify the response in physiologic 
systems, may be bypassed in a system in which fine-tuning of the current is desired. 
Amplification may not be the goal. Under this rubric, VIP, which is not permeable to the 
membrane, would activate the channel by binding directly to it on the extracellular 
surface. Alternatively, VIP could somehow gain access to the cytosolic side of the 
channel by movement through an unidentified transporter. 
If VIP acts directly on the extracellular surface of the channel, one might expect to 
see an initial burst of activity corresponding to association of VIP with the channel. 
Provided this connection involved consumption of VIP, one might also see rundown of 
channel activity as the supply of VIP was depleted. While rundown was observed in 
patches that demonstrated the VIP-stimulated channel, the pattern of rundown argues 
against direct stimulation by VIP. Rundown only occurred in patches after excision, and, 
in fact, was correlated with excision. If rundown were secondary to depletion of VIP, 
then a decrease in conductance should have been observed in both cell-attached and 
excised modes as the supply of VIP in the bath solution was diminished. In vivo, VIP is 
rapidly degraded by extracellular and membrane-associated enzymes. Although these 
experimental conditions did not recreate the milieu in which this reaction might 
conceivably occur in vivo, it seems unlikely that rundown would occur only and reliably 
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with excision. If extracellular stimulation is the mode of action of VIP in human airway 
tissue, then one might reasonably expect to see rundown in the cell-attached mode as a 
natural component of channel gating. Rundown in the cell-attached mode did not occur 
in any of the ten patches with this channel. 
If rundown were secondary to depletion of VIP, one would expect to see 
restoration of activity with addition of VIP after rundown. This maneuver was not 
explored in this protocol. However, the restoration of activity with ATP, although not 
precluding direct VIP activation, does suggest CFTR is phosphorylated, perhaps through 
the proposed cAMP and PKA pathway. 
Factors argue strongly against direct activation of VIP on the cytosolic surface of 
the channel. First, and perhaps most convincing, is that VIP does not cross the cell 
membrane. One must postulate an as yet unidentified transporter by which VIP could 
gain access to the cytosolic side. Alternatively, if a means of access to the cytosolic side 
was lost in the in vitro setting, one might observe channel activity after excision once the 
cytosolic facet of the channel was exposed to VIP in the inside-out patch. In these 
samples, however, channels were apparent in both cell-attached and excised modes. 
Second, if VIP acted on the cytosolic aspect of the channel, an appreciable delay 
as VIP crossed the membrane prior to binding would not be surprising. In all of the S9 
patches demonstrating channel activity with VIP stimulation (n=10), that activity was 
apparent immediately upon seal formation. However, one must allow that the time 
allotted for pretreatment with VIP may have been sufficient for transport across the 
membrane to occur. 
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5-4. VIP Increases Chloride Conductance through a Paracellular Pathway 
Another possible mode for an increase in chloride flow from the basal to the 
apical aspect of epithelial cells is through a paracellular, rather than transcellular, path. 
This formulation involves binding of VIP to receptors to stimulate loosening of tight 
junctions between epithelial cells. This is the least likely mechanism of the chloride 
conductance observed in these experiments. If this were the mechanism of action, it 
would not be revealed by an increase in current observed in the experimental setup we 
employed. Ion flow between cells would not be witnessed during recordings of patches 
of membrane from those cells. Thus, even if VIP does have an effect mediated through a 
paracellular path, it also has the effect reported here attributable to activation of apical 
CFTR chloride channels. 
5-5. VIP Activates ORCC 
The apical membrane of the epithelial cells studied contains a second potentially 
cAMP-regulated channel, the ORCC. Knowing that ORCC can be activated by cAMP, 
one can construct a model in which VIP increases chloride conductance through ORCC 
by augmentation of intracellular cAMP. If cAMP is the path by which VIP stimulates 
chloride flow, then this channel could also serve as the end target of VIP stimulation. 
However, ORCC requires the presence of CFTR in the membrane to be cAMP- 
activated. If VIP modulates chloride conductance through cAMP, IB3-1 cells should 
display fewer activated ORCC than S9 cells due to the lack of CFTR in the IB3-1 cell 
line. Analysis of both cell lines showed that 31% of IB3-1 patches versus 50% of S9 
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patches demonstrated ORCC channels. In contrast to the difference in CFTR chloride 
channel activity, there is no difference (P=0.6882) in the appearance of ORCC. 
Arguing against cAMP as the mediator of VIP and ORCC as a possible end-target 
is the lack of a temporal association between addition of VIP to either S9 or IB3-1 cells 
and appearance of channel activity. While the smaller, 10.4pS±0.39pS current appeared 
in S9 cells pretreated with VIP immediately upon seal formation, the larger current was 
not observed in any patch (S9 or IB3-1) until after initial depolarizing voltages of at least 
+70mV. This is surprising because one would expect to see an increase in PKA- 
dependent ORCC activity corresponding to CFTR activity in the S9 cells, without a 
requirement for voltage activation. 
The sum of the data on ORCC activation in both cell lines does not support a 
mechanism in which VIP increases chloride conductance via cAMP activation. In the S9 
cell line, PKA regulation of ORCC is normal, and one should therefore see an increase in 
ORCC activity above that observed in the IB3-1 cell line if VIP acts through cAMP. One 
explanation is that the number of observations obtained in this study is too small to 
demonstrate a statistically significant difference in ORCC activation between the two cell 
lines. That is, ORCC is in fact activated in the S9 cell line by VIP mediated increase in 
cAMP. Because the kinetics of ORCC channels stimulated by the cAMP pathway differ 
from those stimulated by voltage activation, kinetic analysis of single channel patches 
would provide a means to delineate the mechanism of ORCC activation. Although single 
channel data was not obtained in these samples, future studies could examine the kinetics 
of the ORCC channels observed in these two cell lines to clarify whether VIP is 
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responsible for channel activation. Alternatively, VIP may act directly on CFTR as 
outlined above, or it may elicit activation of CFTR via cAMP in a manner which 
uncouples CFTR regulation of ORCC. 
5-6. Therapeutic Implications of VIP Activation of an Apical Chloride Channel 
In cystic fibrosis severity of disease directly correlates with the amount of 
chloride ion effectively secreted across the apical membrane of various epithelia. In 
people with CF in whom VIP innervation may be abnormal, discovering ways to increase 
putative VIP-induced chloride channels would clearly have little value. However, in 
patients in whom VIP innervation is intact, increased chloride current mediated through 
VIP stimulation could present an attractive therapeutic option that utilizes physiologic 
pathways to treat this systemic disease, whether VIP acts indirectly through a cAMP- 
dependent mechanism or directly on CFTR chloride channels. 
The data in this study strongly suggest that VIP increases apical chloride 
conductance in airway epithelial cells by stimulating CFTR chloride channels. Whether 
VIP acts on CFTR directly, or through increases in intracellular cAMP, remains 
unresolved. If, in fact, VIP is a member of the family of protein agonists that stimulate 
CFTR by increasing cAMP (i.e., methylxanthines, IBMX), then VIP is potentially useful 
in the multitude of CF mutations in which CFTR is made but does not function optimally. 
These categories of mutations create phenotypes characterized by an absolute insufficient 
amount of CFTR, protein that spends a disproportionate amount of time in the closed 
state, or protein that is improperly trafficked to the membrane. The most common CF 
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mutation, AF508, produces a protein without proper trafficking signals. Only a fraction 
of the necessary CFTR arrives to function at the plasma membrane. Similarly, in 
treatment of CF patients with adenovirus vector transfection of wild-type CFTR, 
maintenance of a surfeit of chloride channels in the apical membrane is often a 
therapeutic problem. Targeting agonists that increase cAMP would maximize stimulation 
of CFTR present in the plasma membrane, ensuring that chloride secretion, even in a cell 
with reduced numbers of chloride channels, proceeds most efficiently. 
If, as the data on ORCC activation in this study suggest, VIP stimulates CFTR 
chloride channels through a mechanism that does not involve cAMP as a second 
messenger, then the value of VIP in CF may be even greater. By utilizing VIP as a 
potential CFTR agonist in conjunction with known cAMP agonists, therapies could be 
designed to fully maximize CFTR stimulation. In patients with CF mutations like those 
described above, using VIP to augment PKA-regulated chloride channel activity would 
provide a two-pronged approach to increasing ion movement necessary for airway 
function. 
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